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Abstract	  
Colonoscopy remains the gold standard for detection of dysplasia in the colon. 
Resection of dysplasia at colonoscopy has been shown to reduce the subsequent 
risk of colorectal cancer. With the recent advent of National Bowel Cancer Screening 
Programme the number of colonoscopies performed in the United Kingdom has 
increased significantly. In addition, the recent drive for quality improvement has 
resulted in increased number of dysplastic lesions detected, resected and sent for 
histopathology. This has led to substantial increases in the cost associated with the 
procedure. This thesis investigates how advanced technology can improve detection 
and characterisation of dysplasia at colonoscopy, potentially contributing to time and 
cost savings. 
The introduction reviews the literature on dysplasia detection at colonoscopy, both in 
terms of basic withdrawal technique and how advanced technology can help reduce 
miss rates. The significance of small colorectal polyps is reviewed and the accuracy 
of recent colonoscopic technologies in polyp characterization considered. 
Three studies examined detection of dysplasia: a small randomized control trial 
showed that magnetic endoscope imager did not improve caecal intubation or 
dysplasia detection rates in selected patients when used by experienced 
colonoscopists. Two studies, one of which was in patients with long standing colitis, 
did not demonstrate the benefit of narrow band imaging for detection of dysplasia. 
A cohort study revealed that in vivo characterization of dysplasia can be done 
accurately and is feasible in routine clinical practice although the inter-observer 
agreement is moderate at best as assessed by a retrospective study. A computer 
algorithm was devised to attempt to reduce the inter-observer variability and has 
shown promising results in a pilot study. A training module on the use of narrow 
band imaging in characterization was developed and validated leading to improved 
accuracy and reduced variability amongst the participants. Finally, a quality 
assurance study confirmed that the still photographs of polyps are adequate record 
of optical diagnosis. 
3 
 
 
 
 
Dedicated	  to	  my	  family	  
without	  whom	  none	  of	  this	  
would	  have	  been	  possible.	  
 
4 
Preface	  
This thesis represents original work by the author carried out at the Wolfson Unit for 
Endoscopy, St. Mark’s Hospital and has not been presented in any other form to any 
other university. Where use has been made of the work of others it is acknowledged. 
The work presented was carried out under the supervision of Dr Brian Saunders 
(Imperial College, London and St Mark’s), Dr Ailsa Hart (Imperial College and St 
Mark’s) and Dr David Burling (St Mark’s). 
5 
Acknowledgements	  
I am greatly indebted to to a large number of individuals for their inspiration and 
support and without whom this thesis would not have been possible. 
First and foremost my main supervisor and mentor, Dr Brian Saunders, whose 
commitment to excellence in the field of colonoscopy formed the driving force behind 
this thesis. His enthusiasm, unquestioning support and sound advice have made the 
current work possible. I am eternally grateful to have been given the opportunity to 
work at the Wolfson Endoscopy Unit. Also to Dr Siwan Thomas-Gibson for her 
unrecompensed encouragement, support and guidance and for being a fantastic role 
model. I thank Dr James East, my predecessor at the Wolfson Unit, for being 
inspirational, endlessly supportive and a great sounding board.  
Dr Ailsa Hart and Dr David Burling, my co-supervisors, provided analytical opinions 
and gentle guidance when needed. I am grateful to Prof Thomas Gunther for his help 
with re-reporting of histopathological specimens done in his free time.  
I would not have been able to complete this work without many individuals at the 
Wolfson Endoscopy Unit and I feel priviledged to have worked with them. Particular 
mention has to go to Nicola Palmer for her patience in recruiting and consenting 
patients, reliable common sense and humour; Maggie Vance for her unwavering 
support; Steve Preston, whose IT skills were crucial in many of the projects; Jean 
Mannings for organising colonoscopy lists; Adam Haycock, Edward Despott and 
Aymer Postgate for being wonderful and helpful colleagues; Phil Tozer, a fellow 
Imperial MD student, for sound advice and a dry sense of humour. 
Dr Noriko Suzuki, Miss Ripple Man, Miss Sue Clark, Mr Ian Jenkins, Dr Naila Arebi, 
Dr Ayesha Akbar, Dr Simon Gabe, Sr Jane Butcher and many of the RMOs and 
RSOs gave up their time to contribute to my projects for which I am immensly 
thankful. I am grateful to the nurses and clerical staff at the endoscopy unit for 
putting up with research lists which frequently finished late. 
I thank Paul Bassett for his statistical advice and analysis, which have greatly 
contributed to the interpretation and evaluation of the results. 
 
6 
I would like to thank all the patients who, often only too willingly, consented to take 
part in the research, which is integral to work at St Mark’s hospital.  
Finally, my infinite thanks to Jonno for eagerly anticipated caffeine fuelled breaks 
that made me see things clearly. 
7 
List	  of	  Contents	  
Chapter 1	   Introduction 16	  
1.1	   Overview 16	  
1.2	   Colorectal Cancer: The Scale of The Problem 16	  
1.2.1	   Development of colorectal cancer 16	  
1.2.2	   Dysplasia as a precursor to colorectal cancer 18	  
1.2.3	   Role of colonoscopy in colorectal cancer prevention 19	  
1.2.4	   Missed dysplasia and cancer 20	  
1.3	   Improving Dysplasia Detection at Colonoscopy 25	  
1.3.1	   Examination technique 26	  
1.3.2	   Magnetic endoscopic imaging 26	  
1.3.3	   Advanced colonic mucosal imaging 27	  
1.4	   The cost of improved dysplasia detection 30	  
1.4.1	   Significance of small colorectal polyps 30	  
1.4.2	   Characterisation of small polyps at colonoscopy 34	  
1.5	   Reducing performance gaps between colonoscopists with different levels of 
expertise 41	  
1.5.1	   Computer aided diagnosis (CAD) 41	  
1.5.2	   Training in advanced endoscopic imaging 41	  
1.5.3	   Quality assurance 43	  
1.6	   Hypothesis 43	  
1.6.1	   Lesion detection 43	  
1.6.2	   Lesion characterisation 44	  
1.6.3	   Thesis strategy 44	  
Chapter 2	   Does ScopeGuide improve caecal intubation? A randomized 
controlled trial 46	  
2.1	   Background and Aims 46	  
2.2	   Methods 48	  
2.2.1	   Participants 48	  
2.2.2	   Study design and randomization 48	  
8 
2.2.3	   Colonoscopic protocol 49	  
2.2.4	   Primary and secondary outcomes 50	  
2.2.5	   Statistical analysis 50	  
2.3	   Results 50	  
2.3.1	   Participants 50	  
2.3.2	   Caecal intubation rate and time 52	  
2.3.3	   Patient comfort levels 52	  
2.3.4	   Polyp detection rate 53	  
2.4	   Discussion 53	  
Chapter 3	   Narrow band imaging for detection of dysplasia in colitis: a 
randomized controlled trial 56	  
3.1	   Background and Aims 56	  
3.2	   Methods 57	  
3.2.1	   Participants 57	  
3.2.2	   Study design and randomization 57	  
3.2.3	   Colonoscopic protocol 57	  
3.2.4	   Histopathological evaluation 58	  
3.2.5	   Primary and secondary outcomes 59	  
3.2.6	   Statistical methods 59	  
3.3	   Results 60	  
3.3.1	   Participants 60	  
3.3.2	   Detection of dysplasia in targeted biopsies 61	  
3.3.3	   Detection of dysplasia in non-targeted random biopsies 63	  
3.4	   Discussion 64	  
Chapter 4	   Narrow band imaging for detection of neoplastic and non-
neoplastic lesions in the colon: a meta-analysis 67	  
4.1	   Background and Aims 67	  
4.2	   Methods 68	  
4.2.1	   Study selection 68	  
4.2.2	   Data extraction 69	  
4.2.3	   Data analysis 69	  
9 
4.3	   Results 69	  
4.3.1	   Primary outcomes 72	  
4.3.2	   Secondary outcomes 73	  
4.4	   Discussion 75	  
Chapter 5	   In-vivo characterization of dysplasia 77	  
5.1	   Background and Aims 77	  
5.2	   Methods 78	  
5.2.1	   Patients 78	  
5.2.2	   Procedures 78	  
5.2.3	   Statistical analysis 80	  
5.3	   Results 80	  
5.4	   Discussion 87	  
Chapter 6	   Inter-observer agreement in characterisation of dysplasia 92	  
6.1	   Background and Aims 92	  
6.2	   Methods 93	  
6.2.1	   Images and observers 93	  
6.2.2	   Evaluation of images 94	  
6.2.3	   Statistical analysis 94	  
6.3	   Results 95	  
6.3.1	   Patient and Polyp Characteristics 95	  
6.3.2	   Image quality 95	  
6.3.3	   Inter-observer agreement for polyp histology 95	  
6.3.4	   Accuracy for prediction of polyp histology 96	  
6.4	   Discussion 98	  
Chapter 7	   Development of computer algorithm to aid in characterization 
of colonic dysplasia 101	  
7.1	   Background and Aims 101	  
7.2	   Methods 102	  
7.2.1	   Construction of the algorithm 102	  
10 
7.3	   Results 106	  
7.3.1	   Lucera images 106	  
7.3.2	   Exera images 107	  
7.4	   Discussion 108	  
Chapter 8	   Use of narrow band imaging in characterization of dysplasia: a 
training module 111	  
8.1	   Background and Aims 111	  
8.2	   Methods 111	  
8.2.1	   Module development 111	  
8.2.2	   Module validation 114	  
8.2.3	   Statistical analysis 114	  
8.3	   Results 115	  
8.3.1	   Participants 115	  
8.3.2	   Construct validity 116	  
8.3.3	   Content validity 116	  
8.3.4	   Inter-observer agreement 117	  
8.4	   Discussion 118	  
Chapter 9	   Use of still photographs as photo-documentation in 
endoscopy: a quality assurance study 120	  
9.1	   Background and Aims 120	  
9.2	   Methods 121	  
9.2.1	   Polyps images 121	  
9.2.2	   Expert reviewers 122	  
9.2.3	   Intra-observer agreement 122	  
9.2.4	   Primary and secondary outcomes 122	  
9.2.5	   Statistics 123	  
9.3	   Results 123	  
9.3.1	   Polyps 123	  
9.3.2	   Agreement between expert reviewers 123	  
9.3.3	   Intra-observer agreement 124	  
9.3.4	   Sensitivity, specificity and accuracy of diagnosis 124	  
11 
9.4	   Discussion 125	  
Chapter 10	   Conclusions and future directions 128	  
Chapter 11	   Bibliography 132	  
Appendix 1	   Publications and presentations arising from this thesis 153	  
Original articles 153	  
Reviews 153	  
Published abstracts 153	  
Personal presentations 154	  
Appendix 2	   Discard 2 156	  
 
 
12 
List	  of	  Tables	  
Table 1.	   Summary of trials of chromoendoscopy in ulcerative colitis surveillance: Proportion 
of patients with at least one dysplastic lesion detected with each method 28	  
Table 2.	   Proportion of small or diminutive adenomas with advanced histology (Adapted from 
(110)) 32	  
Table 3.	   Factors predictive of a technically difficult colonoscopy 48	  
Table 4.	   Baseline characteristics of patients who completed the trial 52	  
Table 5.	   The amount of sedation used in each arm 53	  
Table 6.	   Baseline characteristics of patients who completed the trial 61	  
Table 7.	   Per patient comparisons of the primary and secondary outcomes 63	  
Table 8.	   Per lesion comparison between NBI and WLE arms 63	  
Table 9.	   Characteristics of the studies included in the meta-analysis 71	  
Table 10.	   Demographics of participants 82	  
Table 11.	   Per-polyp analysis for polyps for which both optical and histological diagnoses 
were available 84	  
Table 12.	   Differences in diagnosis according to polyp size 84	  
Table 13.	   Two patients with discrepancies between follow-up between optical and 
histological diagnosis (BSG Guidelines) 85	  
Table 14.	   Surveillance intervals in patients with high-risk lesions using optical diagnosis and 
formal histopathology 85	  
Table 15.	   Inter-observer agreement among expert and non-expert endoscopists when 
characterizing small polyps using still images obtained with WLE, AFI, NBI and 
NBimag 96	  
Table 16.	   Sensitivity, specificity and accuracy of WLE, AFI, NBI and NBImag for expert 
colonoscopists (n=4) 96	  
Table 17.	   Sensitivity, specificity and accuracy of WLE, AFI, NBI and NBImag for non-expert 
colonoscopists (n=5) 97	  
Table 18.	   Sensitivity, specificity and accuracy of AFI, NBI and NBImag when compared to 
WLE for expert colonoscopists (n=4, Paired exact test, all p values Bonferroni 
adjusted) 97	  
Table 19.	   Sensitivity, specificity and accuracy of AFI, NBI and NBImag when compared to 
WLE for non-expert colonoscopists (n=5, Paired exact test, all p values 
Bonferroni adjusted) 97	  
Table 20.	   Exact observations for NBImag and WLE, for experts and non-experts 98	  
Table 21.	   Sensitivity, specificity and accuracy of Scope-AidTM (Lucera images) 106	  
Table 22.	   Sensitivity, specificity and accuracy of ScopeAidTM (Exera images) 108	  
Table 23.	   Previous colonoscopic experience of participants 115	  
13 
Table 24.	   Comparison of baseline accuracy between the groups 116	  
Table 25.	   Comparison of pre and post-training test accuracy 116	  
Table 26.	   Comparison of pre and post-training test sensitivity 117	  
Table 27.	   Comparison of pre and post-training test specificity 117	  
Table 28.	   Kappa coefficients for inter-observer agreement for pre and post-training 117	  
Table 29.	   Agreement between expert reviewers and in vivo diagnosis made by BPS 124	  
Table 30.	   Sensitivity, specificity and accuracy of diagnosis for expert reviewers 124	  
Table 31.	   Sensitivity, specificity and accuracy of diagnoses made with high vs. low 
confidence 125	  
Table 32.	   Sensitivity, specificity and accuracy of diagnoses for low vs. high quality images 125	  
 
14 
List	  of	  Figures	  
Figure 1.	   Genetic events in colorectal carcinogenesis 17	  
Figure 2.	   Low grade dysplasia in the crypt on the left of the picture 18	  
Figure 3.	   British Society of Gastroenterology guidelines for polyp surveillance 33	  
Figure 4.	   Sensitivity, specificity and accuracy for small polyp characterisation using 
conventional white light colonoscopy 35	  
Figure 5.	   Kudo pit-pattern classification 36	  
Figure 6.	   Type 1 pit-pattern 36	  
Figure 7.	   Type 2 pit-pattern 37	  
Figure 8.	   Type 3L pit-pattern 37	  
Figure 9.	   Type 3s pit-pattern 38	  
Figure 10.	   Type 4 pit-pattern 38	  
Figure 11.	   Type 5 pit-pattern 39	  
Figure 12.	   Sensitivity, specificity and accuracy for small polyp characterisation using 
magnifying chromoendoscopy 39	  
Figure 13.	   Sensitivity, specificity and accuracy for small polyp characterisation using NBI 40	  
Figure 14.	   An example of a ‘steep’ learning curve 42	  
Figure 15.	   Participant flow through the trial 51	  
Figure 16.	   Participant flow through the trial 60	  
Figure 17.	   Flow chart of articles selected 70	  
Figure 18.	   Forrest plot. Total number of adenomas detected 72	  
Figure 19.	   Forrest plot. Number of patients with ≥ 1 adenoma detected. 73	  
Figure 20.	   Forrest plot. Detection of flat/sessile/depressed adenomas. 74	  
Figure 21.	   Flow diagram of participants through the study 81	  
Figure 22.	   Surveillance intervals using optical and histopathological diagnosis 86	  
Figure 23.	   The differences between histograms were then exploited to construct the 
features for discrimination between the two types of polyps 103	  
Figure 24.	   Orientation dominance fields for adenomatous and hyperplastic polyps 103	  
Figure 25.	   Mean normalised cumulative histograms of polyps and surrounding normal 
mucosa 104	  
Figure 26.	   Identifying the area of the colour chart that best discriminates between the two types 
of polyp. 105	  
Figure 27.	   ROC curve generated by using features separately and combined for Lucera 
images 107	  
15 
Figure 28.	   ROC curve generated by using features separately and combined for Exera 
images 108	  
Figure 29.	    Screenshot from NBI training module 113	  
Figure 30.	   Screenshot from NBI training module 113	  
 
16 
Chapter	  1 	  Introduction	  
1.1 Overview	  
Colonoscopy remains the preferred modality for detection of dysplastic lesions in the 
colon and is the procedure of choice for many national bowel cancer screening 
programmes. In the USA alone more than 14 million screening colonoscopies are 
performed annually (1). The use of colonoscopy as a screening tool in asymptomatic 
population in addition to emerging literature on missed cancers at colonoscopy has 
driven improvements in quality of the procedure. One of the most validated quality 
indicators is adenoma detection rate (ADR) and, in published literature, at least the 
reported ADRs have been increasing over the last few years. This has led to 
increased costs associated with colonoscopy, both in terms of time taken to resect 
and retrieve dysplastic lesions and subsequent histopathological analysis. An ability 
to diagnose small dysplastic lesions in vivo would potentially reduce the need for 
histopathology making the procedure more cost-effective. This thesis explores how 
advanced colonoscopic technology could be used to improve detection and 
characterization of dysplastic lesions during colonoscopy. 
1.2 Colorectal	  Cancer:	  The	  Scale	  of	  The	  Problem	  
Colorectal cancer (CRC) is the second leading cause of cancer death in England 
with approximately 40000 new cases diagnosed each year and around 16000 
deaths. According to Cancer Research UK, 1 in 14 men and 1 in 19 women will 
develop CRC at some point in their lives. Although in the UK survival from CRC has 
doubled over the last 30 years, overall 5-year survival is still just over 50% and as 
such amongst the lowest in Europe (2). 
1.2.1 Development	  of	  colorectal	  cancer	  
The majority of sporadic colorectal cancer develops from polypoid adenomas, in a 
well described ‘adenoma-carcinoma’ genetic sequence Figure 1 (3). It involves a 
progression from normal epithelium to low-grade dysplastic adenoma to larger, 
protruding adenoma with high-risk features (high-grade dysplasia or villous 
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component) and finally to invasive cancer as a result of mutations in a number of 
genes, including APC, KRAS and p-53 (3). This pathway is thought to account for 
approximately two thirds of all colorectal cancers. 
 
Figure 1. Genetic events in colorectal carcinogenesis 
 
Approximately 5% of colorectal cancers are due to an autosomally dominant familial 
condition: Lynch syndrome. Patients with Lynch syndrome (previously known as 
hereditary non-polyposis colorectal cancer, HNPCC) have mutations in DNA mismatch 
repair genes. The mismatch repair proteins are responsible for ensuring accurate DNA 
replication and when defective, they are unable to control mutations in key sites in the 
genome. These sites include ‘microsatellite’ regions, resulting in microsatellite instability. 
Microsatellites are short repetitive sequences of DNA found, amongst others, in 
genes involved in cell proliferation and apoptosis. More than 90% of Lynch syndrome 
cancers display microsatellite instability (MSI-H) (4). 
However MSI-H is not restricted to Lynch syndrome and also occurs in up to 15% of 
sporadic colorectal cancer (5, 6). These cancers have molecular changes different to 
those found in Lynch syndrome and in particular are characterised by DNA 
methylation and mutations of the oncogene BRAF. DNA methylation is a mechanism 
for silencing various tumour suppressor genes including the mismatch repair gene 
MLH1 (7). Sporadic colorectal cancers that are MSI-H are seen more frequently in 
elderly women (>70 years) and are typically found in the proximal colon (caecum 
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and ascending colon). Molecular studies suggest that sessile serrated adenomas, 
which endoscopically resemble large hyperplastic polyps (>10mm in size) and are 
morphologically sessile or minimally elevated, and have predilection for the right 
colon, are precursor lesions to at least some MSI-H cancers (8, 9). 
1.2.2 Dysplasia	  as	  a	  precursor	  to	  colorectal	  cancer	  
Dysplasia (Figure 2) is defined as unequivocal neoplastic change of the colonic 
epithelium without invasion of the lamina propria. The terms dysplasia and neoplasia 
are used interchangeably. The Vienna classification (10) of gastrointestinal neoplasia 
has five categories: 
1 Negative for dysplasia/neoplasia 
2 Indefinite for dysplasia/neoplasia 
3 Non-invasive low grade neoplasia/dysplasia (low grade adenoma) 
4 Non-invasive high grade neoplasia/dysplasia (high grade adenoma) 
5 Invasive neoplasia 
 
 
Figure 2. Low grade dysplasia in the crypt on the left of the picture 
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The vast majority of low-grade adenomas will not progress to high-grade adenomas 
and subsequently to invasive cancer, but it is currently impossible to identify which 
ones will do. 
1.2.3 Role	  of	  colonoscopy	  in	  colorectal	  cancer	  prevention	  
Colonoscopy is the current gold standard for detection of dysplastic lesions in the 
colon and as such has been adopted as a primary screening tool for CRC in a 
number of Western countries. In England, the NHS Bowel Cancer Screening 
Programme began in 2006 and, as of April 2010 was established across 99.4% of 
the country. It offers Faecal Occult Blood Test (FOBT) screening every two years to 
men and women aged 60-75, followed by colonoscopy for those who test positive. 
This has resulted in a dramatically increased demand for colonoscopy. In United 
States alone, over 14 million screening colonoscopies are performed each year (1). 
Colonoscopy offers immediate therapeutic capability and resection of adenomas 
halts the adenoma-carcinoma sequence, reducing the risk of CRC development. The 
evidence that colonoscopy prevents incident CRC and reduces mortality is indirect, 
but substantial. Cohort studies of colonoscopy and polypectomy have suggested that 
against the SEER (Surveillance Epidemiology and End Results) data, the rate of 
CRC detected was 76-90% lower than expected for the population (11, 12). An 
Ontario population-based cohort study of 2412077 individuals 50-90 years of age 
followed over 14 years, found that for every 1% increase in complete colonoscopy 
rate, the hazard of death from CRC decreased by 3% (13). Additional evidence for a 
protective effect of colonoscopy with polypectomy can be extrapolated from flexible 
sigmoidoscopy trials, with the most recent randomised controlled trial (14) that 
enrolled 170 432 participants demonstrating that the incidence of CRC in people 
attending for screening was reduced by 33% (0.67; 95% CI 0.60-0.76) and mortality 
by 43% (0.57; 95% CI 0.45-0.72). 
Currently, most polyps seen at colonoscopy are removed by endoscopic resection 
and sent for histopathology. Bleeding and perforation are the most common 
complications of polypectomy, with risks of 0-4% (15, 16) and 0-0.23% (17, 18) 
respectively reported in the literature, although they are likely to be higher in routine 
clinical practice. 
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1.2.4 Missed	  dysplasia	  and	  cancer	  
Although colonoscopy is perceived as a definite whole colon examination it is 
associated with a varying risk of missing dysplasia and CRC. Following the results of 
the US National Polyp Study which suggested that colonoscopy was associated with 
a significantly lower rate of CRC, three chemoprevention adenoma trials showed 
little or no difference in the incidence of CRC compared to the background 
population (19-21). In addition, evidence has emerged that 3-5% of patients 
presenting with CRC have had a colonoscopy, which did not detect CRC within 3-5 
years (22, 23). A retrospective study from Indiana reported that 47 of 941 (5%) CRC 
patients had a reportedly normal colonoscopy within 3 years prior to their diagnosis 
(24). Similar findings were reported by a large population based cohort study of 
12487 patients with CRC, 2-6% of whom had a diagnosis made within 3 years of 
colonoscopy, with right-sided CRC associated with greater risk (23). It appears that 
colonoscopy is less effective in the right colon. A population-based case control 
study from Ontario of 10942 patients with CRC and 51460 controls, reported that 
colonoscopy was associated with fewer deaths from left-sided CRC (OR 0.33; 95% 
CI 0.28-0.39) but not from right-sided CRC (OR 0.99; 95% CI 0.86-1.14). Further 
evidence for reduced protection of colonoscopy for right-sided CRC comes from a 
German statewide cross-sectional study of 3287 participants in a screening 
programme that assessed the association of advanced neoplasia (cancer and 
advanced adenomas, defined as >1cm in size or presence of tubulovillous or villous 
components or high grade dysplasia) and colonoscopy within the previous 10 years. 
Prevalence ratios for advanced neoplasia were overall 0.52 (95% CI 0.37-0.73), left-
sided 0.33 (95% CI 0.21-0.53) and right-sided 1.05 (95% CI 0.63-1.76). There are 
several possible explanations for this finding, including those related to quality of 
colonoscopy as well as the biology of dysplastic lesions. 
1.2.4.1 Quality	  of	  colonoscopy	  
Lesion not reached 
Caecal intubation rate as the marker of complete colonoscopy is one of the key quality 
indicators of colonoscopy (25). Most national societies have set targets for caecal 
intubation rates to be ≥90% (>95% in screening cases in the USA) (26, 27). A recent 
study (28) has shown that patients undergoing colonoscopy by an endoscopist with 
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caecal intubation rate ≥95% were less likely to have a ‘missed’ CRC (defined as CRC 
diagnosed in patients who had a complete colonoscopy 7 to 36 months before 
diagnosis of cancer) than if performed by an endoscopist with <80% caecal intubation 
rate (OR 0.72, 95% CI 0.53-0.97 for proximal cancers and OR 0.73, 95% CI 0.54-0.97 
for distal cancers). There is evidence, however, that incomplete colonoscopy is a 
significant issue in routine clinical practice and a number of studies have evaluated 
caecal intubation rates. An audit of 9223 colonoscopies performed in the UK reported 
a caecal intubation rate of 76.9% (29), a figure not dissimilar to that reported from the 
US academic hospital, 85.1% (30). In a study of 331 608 colonoscopies in Ontario 
during 1999-2003, caecal intubation rate of 86.9% was recorded (31). Patients with 
incomplete colonoscopy were more likely to be older, more likely to be female and 
have had a prior abdominal or pelvic surgery (31). 
There have been several series published in the literature assessing factors related 
to incomplete colonoscopy. Lower total colonoscopy completion rates have been 
reported in patients who are older (31, 32), have low body mass index (33, 34), who 
have had previous abdominal or pelvic surgery (31, 32, 35) and in women compared 
to men (31, 32, 36) (37). A study assessing factors predictive of pain and difficulty at 
colonoscopy found that it was technically more difficult and painful in women (34, 38, 
39). The reasons for difficulties at colonoscopy, other than strictures, inflammation 
and poor bowel preparation are related to, either, a redundant and mobile colon or 
difficult, angulated sigmoid colon (40). Women have longer total colonic length, in 
particularly longer transverse colons (41) and are also more likely to have mobile, 
unzygosed colons (42), leading to recurrent looping of the colonoscope and a 
technically difficult intubation. The loops frequently preclude the progression of the 
examination and lead to pain for the patients due to stretching of the colonic wall and 
mesenteric attachments (43). In one study 90% of all pain episodes coincided with 
either looping or straightening of the colonoscope shaft (44). To achieve complete 
colonoscopy safely and with least discomfort to the patients most loops need to be 
straightened out (45) with a combination of manoeuvres, including 
anticlockwise/clockwise twist (torque), withdrawal, changing the patient position and 
abdominal hand pressure. This is often done with ‘trial and error’ as it is impossible 
to characterise precisely the type of loop formed at conventional colonoscopy without 
the aid of imaging. 
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Expert colonoscopists are often able to achieve caecal intubation in patients who 
have had a previously failed colonoscopy performed by another colonoscopist (40). 
In addition, there is growing evidence that the specialty of the colonoscopist is 
important for the quality of colonoscopy. There are a number of studies that have 
reported that having the colonoscopy performed by a non-gastroenterologist is an 
independent risk factor for interval cancer (23, 24). 
Lesion not seen 
Although large lesions and cancers are often seen during the insertion phase of 
colonoscopy, it is the time taken for withdrawal, from caecum to rectum that is 
particularly important for detection of small and subtle lesions. 
A number of back-to back colonoscopy studies have been performed to assess the 
miss rate of colonoscopy. A back-to-back study involves two colonoscopies 
performed on the same patient, immediately one after the other, either by the same 
or a different endoscopist. All lesions detected during first examination are removed 
and therefore the ones found on the second one are termed ‘missed lesions’. A 
recent systematic review of these studies found the miss rate for adenomas of all 
sizes was 22% (95% CI 19-26%), 2.1% (95% CI 0.3-7.3%) for adenomas ≥10 mm 
and 26% (95% CI 27-35) for those 1-5 mm in size (46). In addition, a European 
multicentre prospective back-to-back study reported a miss rate for all adenomas of 
20% and worryingly 9% for advanced adenomas (47). Further evidence for miss 
rates at colonoscopy comes from studies that have used segmental unblinding of CT 
colonography results to colonoscopists during withdrawal. After colonoscopic 
examination of each segment of the bowel is completed with detected lesions 
recorded, the results of CT colonography are revealed to the colonoscopist who then 
intubates the required segment again if an additional lesion had been detected with 
CT colonography. These studies have revealed an even higher miss rates of 
adenomas at colonoscopy than the back-to back studies, with 12-17% of adenomas 
≥ 10mm missed (48). The majority of lesions missed were located either on the 
proximal side of the fold or close to the anal verge, areas often difficult to visualize 
with a standard colonoscope. 
Lesions are likely to be missed due a combination of factors, relating to the colon, 
the colonoscopist and the procedure itself. Adequate mucosal visualization is a pre-
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requisite for a high quality colonoscopy. The first step in achieving this is to attempt 
to clean the colon of stool. Multiple bowel preparations are used worldwide and there 
is no convincing evidence for superior efficacy of one particular type (49, 50). Quality 
of bowel preparation is related to adenoma and cancer detection rates and its 
documentation is one of the proposed quality indicators of colonoscopy (25). In a 
large multi-centre study, lower quality of bowel preparation was associated with 
reduced detection rates of adenomas (51). 
Other factors that affect mucosal visualisation include adequate colonic distension, 
probably improved by anti-spasmodic medication (52, 53) and patient position 
changes (54) and time taken for withdrawal. In a study that included 12 private 
practice gastroenterologists in the US, those who spent longer than 6 minutes 
withdrawing the colonoscope had a 6.6% large adenoma (≥10mm) detection rate 
compared to 3% in those who had a withdrawal time less than 6 minutes (55). This 
study also revealed a large variation in the operator performance with 10-fold 
difference in adenoma detection rate (ADR) overall and 3-4 fold difference for large 
adenomas. Detection of small adenomas correlated with detection of large 
adenomas. Similar findings were reported in a flexible sigmoidoscopy trial in the UK, 
where the adenoma detection rate varied from 9% to 16% between different 
colonoscopists (56). The differences in ADR remained significant even when the 
other possible confounders had been corrected for (sex, age, family history, cigarette 
smoking, specialty of the colonoscopists and previous experience) leading the 
authors to conclude that differences in ADR between colonoscopists reflect true 
differences in performance. Other studies, as discussed earlier, have reported that 
the specialty of colonoscopists, as a proxy for better training and greater experience, 
affects miss rates, with one study demonstrating a cancer miss rate of 3% for 
gastroenterologists versus 13% for non-gastroenterologists, although differences 
exist among the latter as well (57). 
This data has led to renewed interest in the quality of colonoscopy and a focus on 
ADR as one of the colonoscopy quality indicators (25, 58). The Global Rating Scale 
for Endoscopy quality standard includes ADR ≥10% for all colonoscopies whilst for 
FOBT positive screenees within the BCSP, the target ADR ≥35%. Similar quality 
standards are established in the USA, where among healthy asymptomatic patients 
undergoing screening colonoscopy, adenomas should be detected in ≥25% of men 
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and ≥15% of women aged over 50 (25). However, until recently, the use of ADR as a 
quality indicator had not been validated. A study from Poland (59) assessed the 
relation between ADR and interval cancers in a screening population and found that 
the colonoscopist’s ADR was significantly associated with the risk of interval CRC 
(p=0.008). The hazard ratio for ADR <11% compared to ADR ≥20% was 10.94 (95% 
CI 1.37-87.01). 
Non-polypoid colorectal neoplasms (NP-CRN), comprising flat elevated (0-IIa), flat 
(0-IIb) and flat depressed (0-IIc) lesions, are intrinsically more difficult to detect 
without adequate expertise and technology. Those with a depression (true IIc 
component) are thought to be of particular biological significance and are more likely 
to harbour high-grade dysplasia or submucosal cancer (60) when compared to flat 
elevated or polypoid lesions of the same size. Originally thought to be a Japanese 
phenomenon, NP-CRNs have now been described worldwide. In a UK study of 1000 
colonoscopies, 321 adenomas were detected of which 36% were flat and 0.6% 
depressed. Polyps smaller than 10mm whether polypoid or flat were unlikely to 
contain early cancer, but 29% of flat lesions ≥10mm and 75% of all depressed 
lesions contained early cancer (61). These findings were confirmed by a study from 
the USA reported that non-polypoid lesions were more likely to contain carcinoma 
regardless of size (OR 9.78; 95% CI 3.93-24.4). Although flat and depressed lesions 
represented only 15% of all neoplasms, 54% of all superficial cancers (defined as 
intramucosal and T1 cancers) had non-polypoid morphology (62). Flat and flat 
elevated lesions are subtle and often difficult to detect at standard colonoscopy, 
particularly if mucosal visualization is sub-optimal. 
Enhancing mucosal contrast, either by using a dye or advanced optical imaging may 
improve the detection of subtle, flat lesions. Chromoendoscopy with indigocarmine 
increases detection of flat or depressed CRN (63-66). Although narrow band imaging 
(NBI) probably does not improve overall adenoma detection (67) (68), it may be 
helpful when examining for non-polypoid lesions (69). One study examined 62 
patients from HNPCC families attending for colonoscopic surveillance, first with white 
light colonoscopy then with NBI in a back-to-back study design. The proportion of flat 
adenomas detected with NBI was significantly higher than that detected with white 
light (45% vs. 12%, p=0.03). 
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1.2.4.2 Lesion	  biology	  
Although colonoscopists account for a large proportion of variability seen in 
adenoma detection, some of the patients with interval cancers diagnosed within 3-5 
years of a colonoscopy may have had a normal colonoscopy. The polyp-cancer 
sequence in the colon describes slow evolution of CRC from adenomas (3, 70) but it 
is acknowledged that this is not the only biological pathway to CRC. Up to 10% of 
CRC detected at colonoscopy are small (<1.5cm), flat lesions with little or no 
adenomatous component (71-75) and an alternative hypothesis of CRC 
oncogenesis, involving inactivation of mismatch repair genes through promoter 
methylation, has been proposed, characterized by relatively rapid progression from 
flat adenoma to invasive cancer. The loss of mismatch repair function is recognized 
easily by epiphenomenon of microsatellite instability (MSI-H). A retrospective study 
compared frequency of MSI-H in cancer tissue from 51 patients with interval CRC 
(diagnosed within 5 years of colonoscopy in which all polyps were removed) and 112 
patients who had a CRC detected at the time of colonoscopy. MSI-H was detected in 
30.4% of interval cancers compared to 10.3% of detected cancers, with interval 
cancers 3.7 times likely to be MSI-H (76). Further evidence that interval cancer may 
have a different biology when compared to non-interval cancers comes from studies 
that have assessed CpG island methylator phenotype (CIMP) status of interval 
cancers. CpG island methylator phenotype (CIMP) is another molecular pathway 
thought to be involved in the development of some CRC, with a precursor lesion 
thought to be sessile serrated adenoma (77). CIMP is a genetic epiphenomenon, 
characterized by methylation of cytosine residues of CpG islands in the promoter 
regions of tumour suppressor genes, resulting in transcriptional silencing and loss of 
expression. In one study, CIMP was present in 57% of interval cancers compared to 
33% of non-interval cancers (p=0.004) (78). 
1.3 Improving	  Dysplasia	  Detection	  at	  Colonoscopy	  
Detection of dysplasia at colonoscopy could be improved by addressing a number of 
factors. Careful attention to the basic colonoscopic technique and training of 
colonoscopists are probably the first steps in the process. Issues regarding 
colonoscopic training have been addressed by two doctoral theses from our unit (79) 
One study has demonstrated that a structured training programme (Advanced 
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Colonoscopy Training Week) could improve colonoscopic skills, including the 
withdrawal technique, which is of particular relevance for detection of dysplasia. 
Although a complete colonoscopy may not be possible in all patients even in expert 
hands, a number of adjunctive techniques have been developed to improve 
colonoscopy completion, including magnetic endoscope imaging. However, for those 
patients in whom colonoscopy is impossible or who have other contraindication to 
the procedure, a radiological whole colon examination remains an option, with CT 
colonography (CTC) as the preferred test. 
1.3.1 Examination	  technique	  
A number of relatively simple and basic aspects of colonoscopic technique have 
been studied for their effect on diagnostic performance of colonoscopy, using 
adenoma detection rate as outcome measures. As discussed earlier, good bowel 
preparation and longer withdrawal times are associated with higher ADR (51, 55). 
There is no direct evidence to suggest that the use of antispasmodics is associated 
with improved detection of adenomas, but the benefit is extrapolated from CT 
colonography studies which have demonstrated that use of hyoscine butylbromide 
(Buscopan) and position changes increases colonic distension (52) (54) and the 
percentage of colonic surface visualized. 
1.3.2 Magnetic	  endoscopic	  imaging	  
In the past fluoroscopy was used to visualise loops formed at colonoscopy in order to 
improve the likelihood of caecal intubation. However, it provided relatively poor views, 
was expensive and exposed both the patient and the operator to radiation (80, 81). 
This led to the development of non-radiation based techniques using a magnetic field 
to visualise an inserted endoscope, first described in 1993 (82). Coils that generate a 
pulsed low voltage magnetic field are set at regular distances and are integrated in the 
colonoscope, which is identical in size and function to a standard colonoscope. 
Magnetic impulse is detected by the sensor external to the patient. Each signal is 
modified in such a way that three-dimensional view of the colonoscope is obtained 
which can be viewed either in lateral or antero-posterior position in real time. 
Comparison between colonoscope position and corresponding point on the patient’s 
abdomen can be obtained by using a second mobile sensor coil. 
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In some studies MEI has proved to be of benefit for visualising and removing loops 
during colonoscopy resulting in reduced intubation times and increased completion 
rates, particularly in trainees (83, 84) but these results have not be confirmed in 
other studies (85). Two trials have reported reduced duration of looping and reduced 
numbers of attempts at straightening the colonoscope when the MEI view was 
available although there is disagreement in the literature whether this leads to 
reduced patient discomfort (44, 86) (83). 
Theoretically, MEI should be particularly useful in those patients likely to have a 
technically difficult procedure due to a long colon and its propensity to form loops, by 
enhancing the colonoscopist’s ability to reduce loops making the procedure better 
tolerated. The level of discomfort experienced at colonoscopy is particularly 
important in terms of adherence to a screening programme in countries where 
colonoscopy is performed under minimal sedation (‘conscious sedation’). The study 
described in Chapter 5 addresses the question of whether MEI improves caecal 
intubation rate and comfort levels in patients likely to have a technically difficult 
colonoscopy. 
1.3.3 Advanced	  colonic	  mucosal	  imaging	  
A variety of techniques have been developed to improve the mucosal contrast 
beyond that achieved at standard white light colonoscopy in order to improve the 
detection of small and subtle lesions. These techniques are discussed in the 
following sections. 
1.3.3.1 Chromoendoscopy	  
Chromoendoscopy or ‘dye-spray’ has been used in Japan since the 1970s to enhance 
visualization of colonic mucosa and highlight surface contours. Contrast dyes, such as 
Indigo carmine, that pool into the innominate grooves and highlight any surface 
irregularities are sprayed onto colonic mucosa with a catheter or are applied directly 
down the biopsy channel. This allows easier detection of small flat and depressed 
lesions, in particular. A recent Cochrane review (87) analysed four randomised 
controlled trials (65, 66, 88, 89) that assessed the role of chromoendoscopy in lesion 
detection, outside the setting of polyposis or colitis. It concluded that 
chromoendoscopy significantly increased the number of patients with at least 1 
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dysplastic lesion detected (OR 1.61; 95% CI 1.24-2.09) and patients with 3 or more 
neoplastic lesions detected (OR 2.55; 95% CI 1.49-4.36) but at a cost of increased 
total procedural time compared to white light colonoscopy. Due to uncertain effect and 
perceived clinical inefficiency, dye spray has not currently been advocated for routine 
colonic examinations. This is in contrast to lesion detection in ulcerative colitis, where 
multiple studies, including randomised controlled trials, have demonstrated improved 
dysplasia detection; with a 3-4 fold increase in the number of dysplastic lesions 
detected (90-94) (Table 1). In addition, in patients on a UC surveillance programme, 
the increased time required for chromoendoscopy is likely to be compensated by 
avoiding the need for serial random biopsies. 
Due to perceived increase in time and cost associated with it, pan-colonic 
chromoendoscopy has not been adopted for lesion detection in routine clinical practice 
by Western colonoscopists to date. It is therefore not considered further in this thesis. 
 
Table 1. Summary of trials of chromoendoscopy in ulcerative colitis surveillance: Proportion of 
patients with at least one dysplastic lesion detected with each method 
Author, year White light detection rate Chromoendoscopy detection rate 
Kiesslich, 2003 6/8 (7.5%) 11/80 (13.8%) 
Rutter, 2004 2/100 (2%) 7/100 (7%) 
Hurlstone, 2005 24/250 (6.9%) 69/350 (19.7%) 
Kiesslich, 2007 4/73 (5.5%) 13/84 (15.5%) 
Marion, 2008 9/102 (8.8%) 17/102 (16.7%) 
SUMMARY 45/706 (6.4%) (95% CI 4.6-8.2) 
117/760 (16.3%) 
(95% CI 13.6-19.1) 
 
 
1.3.3.2 Narrow	  band	  imaging	  
Narrow band imaging (NBI; Olympus, Japan (95, 96)) is a new ‘blue light’ optical 
imaging modality available at a push of a button on the colonoscope head. Additional 
optical filters are used, creating narrowed wavelengths of green and blue light, with 
the elimination of red light and therefore centre illumination wavelength is shorter 
(bluer). Narrowing of the spectral bandwidth increases contrast in particular for blood 
vessels as the absorption peak of haemoglobin is 415 nm, whilst shorter wavelength 
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penetrates the mucosa less deeply. As angiogenesis is an early event in adenoma 
formation, theoretically NBI should allow for easier detection of dysplastic lesions. 
There are six published randomised controlled trials (67, 68, 97) (98) on the effect of 
NBI on adenoma detection in a ‘standard risk’ (diagnosis and screening) population, 
two using Lucera and four using Exera processors. Only one study demonstrated a 
significantly improved overall number of adenomas detected with NBI compared to 
white light endoscopy (97). However, studies have reported increased detection of 
hyperplastic polyps (99) and diminutive and flat adenomas (97, 98). These findings 
are supported by a back-to-back study in hereditary nonpolyposis colorectal cancer 
(HNPCC) where a second pass examination with NBI increased the total number of 
adenomas detected, but also the proportion of flat adenomas detected in the NBI 
pass (9/21, 45%) was higher than in the white light pass (3/25, 12%), p=0.03 (69). It 
may be that NBI has little or no benefit in improving overall adenoma detection, but 
may have a role in improved detection of diminutive adenomas and more subtle 
lesions such as flat adenomas and proximal hyperplastic polyps, which may be of 
particular biological significance with more rapid progression to CRC. 
1.3.3.3 Autofluorescence	  
An alternative imaging technique also available to endoscopists at a button push is 
autofluorescence imaging (AFI, Olympus, Japan). AFI uses short wavelength light to 
excite endogenous tissue fluorophores, such as collagen and flavins, which emit 
autofluorescence at a longer wavelength. Neoplastic lesions thicken the mucosa and 
have an increased vascularity. Both these features of neoplasia block the excitation 
light and autofluorescence signal, leading to a void in the autofluorescence signal. 
The background in the AFI false colour image appears green with the voids 
(potential neoplastic lesions) appearing as the co-respondent colour magenta. AFI 
was developed as a “red flag” technique and has been used successfully in the lung 
and the oesophagus to detect neoplastic lesions (100, 101). However, using AFI is 
more difficult in the colon, which is often not ‘clean’ or has fluid pools present, 
leading to multiple false positives and making the system unusable. Three back-to-
back studies have assessed the impact of AFI on adenoma detection and miss rates 
(102) (103, 104). Although two of the studies have reported increased adenoma 
detection with AFI, one only assessed the right colon and the other, with slightly 
30 
irregular randomization, was performed in high-risk patients (HNPCC and familial 
CRC) (103, 104). Based on early experience with AFI, which appeared to have an 
unacceptably high false positive rate, this thesis has not investigated AFI further in 
terms of dysplasia detection. 
1.3.3.4 Advanced	  imaging	  for	  dysplasia	  detection	  in	  long-­‐standing	  ulcerative	  
colitis	  
As discussed earlier there is substantial evidence that chromoendoscopy improves 
dysplasia detection in patients with ulcerative colitis. Most national guidelines for 
surveillance in ulcerative colitis still recommend taking quadrantic random biopsies 
every 10 cm, a practice left over from the days when image resolution was much 
poorer. Prospective chromoendoscopy studies have shown very low yield of 
dysplasia in random biopsies (93, 94, 105). 
Two trials have reported lack of effect of NBI on dysplasia detection. They both come 
from the same unit and have used a randomised crossover study design, with 3 
weeks difference between the procedures, which were performed by different 
endoscopists. In one study, the only difference noted between white light 
colonoscopy and NBI was the increase in number of suspicious lesions biopsied and 
increased false positive rate with NBI (106). In that study, neither NBI with targeted 
biopsies nor white light endoscopy with targeted plus random biopsies detected 
neoplasia in 4/12 patients, prompting authors to conclude that it is too early to stop 
taking additional random biopsies in patients with UC. Using high definition white 
light colonoscopy fewer dysplastic lesions seem to have been missed - out of 1580 
random biopsies taken, only 3 had low grade dysplasia, of which 2 were in near 
proximity to the ‘dysplasia associated lesion or mass’ (DALM) already visualized by 
both NBI and white light. 
Chapter 4 examines the effect of NBI on detection of dysplasia in ulcerative colitis. 
1.4 The	  cost	  of	  improved	  dysplasia	  detection	  
1.4.1 Significance	  of	  small	  colorectal	  polyps	  
Increased awareness of the importance of colonoscopic quality in addition to 
advanced technology available to the operators, has led to increased ADR, at least 
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in the published literature. In a single centre study that compared NBI to high 
definition white light, no benefit in terms of adenoma detection was demonstrated for 
NBI but the ADR in the white light group (67%) was the highest reported in the 
literature (67). High prevalence rates of adenomas were primarily accounted for by 
detection of large number of diminutive (≤5mm) adenomas. Other studies have 
supported the finding that more than 90% of polyps detected at colonoscopy are 
small, (6-9mm) or diminutive (≤5mm), with the latter making up the majority (107-
109). In a study of 13 992 asymptomatic patients who had a screening colonoscopy, 
6360 (45%) of patients had polyps and 83% of those had a largest polyp that was 
≤9mm in size (107). Furthermore, only 2549 out of 4942 (52%) were neoplastic with 
the rest composed of hyperplastic and inflammatory polyps and lymphoid 
aggregates. Similar findings were reported in a retrospective study of 10 034 patients 
who underwent colonoscopy over a 5-year period (109). Polyps ≤5mm represented 
81.6% of all polyps removed and of those 47.9% were tubular adenomas. Risk of 
cancer or advanced features (high-grade dysplasia or villous component >25%) in 
small, and particularly, in diminutive polyps is low (Table 2). 
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Table 2. Proportion of small or diminutive adenomas with advanced histology (Adapted from (110)) 
Study 
Total number 
of diminutive 
adenomas 
[size range] 
Total 
diminutive 
advanced 
histology 
(%)‡ 
Total number 
of small 
adenomas 
[size range] 
Total small 
advanced 
histology 
Total small 
Carcinoma 
Shinya and 
Wolff 1979 
- - 1661 [5-9mm] 249 
(15.0%)† 
8 (0.5%) 
National Polyp 
Study 
1990 
1270 [<6mm] 25 
(2.0%)† 
1230 (6-10mm) 155 
(12.6%)†  
- 
Gschwantler 
2002 
3016 [<5mm] 104 
(3.4%)* 
561 
(18.6%)† 
2789 (5-10mm) 350 
(12.5%)* 
1080 
(38.7%)† 
26 (0.9%) 
Butterly et al. 
2006 
1305 [<6mm] 
 
34 
(2.6%)† 
487 (6-9mm) 
921 (5-10mm) 
38 
(7.8%)† 
85 
(9.2%)† 
2 (0.4%) 
8 (0.9%) 
Sprung 
2006 [abstract] 
- - 6694 (5-10mm) - 2 (0.03%) 
Kim 
2007# 
759 (≤5mm) 3 
(0.4%) 
291 (6-9mm) 11 (3.8%)†  0 (0%) 
Lieberman 
2008#¶ 
3744 (≤5mm) 62 
(1.7%) 
1198 (6-9mm) 79 (6.6%) 2 (0.2%) 
Rex 
2009 
4211 (≤5mm) 79 
(0.87%) 
689 (6-9mm) 68 (5.3%) 4 (0.04%) 
 
*High-grade dysplasia only 
†High grade dysplasia, villous and tubulovillous morphology (>25% villous elements) morphology, not 
invasive carcinoma. 
‡Butterly et al. and Lieberman et al reported one invasive carcinoma at this size category, 
Gschwantler et al., zero. 
# Screening population 
Data on the largest polyp found at colonoscopy only 
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Prevalence of cancer within diminutive polyps is extremely low – a systematic review 
of 4 screening studies has reported a rate of 5/13 630 (0.04%), requiring 2726 
polypectomies to detect one cancer. Assuming a 5.6% prevalence of advanced 
adenomas and 3.3% per year progression of advanced adenomas into cancer, the 
five year CRC risk associated with 4.6% of advanced neoplasia represented by 
diminutive polyps would be 0.04%, compared to 0.07% 5-year risk associated with 6-
9mm polyps (111). As diminutive polyps are of such limited significance, some 
colonoscopic imaging tests such as CT colonography do not report them (109). 
Approximately 50% of small polyps are non-neoplastic (109, 110) and therefore a 
large number of polypectomies are performed unnecessarily, increasing the risks of 
the procedure. Even small polyps, with little risk of harboring cancer, are currently 
sent for histology as the number of adenomas is one of the best determinants of long 
term risk of advanced neoplasia and allows an informed decision regarding future 
surveillance intervals (26, 112, 113). British Society of Gastroenterology guidelines 
pragmatically use the size and number of adenomas as the main determinants of 
surveillance intervals Figure 3. 
 
Figure 3. British Society of Gastroenterology guidelines for polyp surveillance 
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Cost of sending all small and diminutive polyps for histopathology is substantial and 
represents a major contribution to the overall cost of colonoscopy. An ability to correctly 
diagnose a small polyp (< 10mm) during colonoscopy (optical diagnosis) would allow for 
recto-sigmoid hyperplastic polyps to be left in situ and for small adenomas to be 
resected and discarded without a need to retrieve the polyp for formal histopathology, 
especially as 7-19% of small polyps (114, 115) may not be successfully retrieved or are 
unsuitable for histological analysis because of diathermy artifact. In addition, small 
polyps may be misclassified at standard histopathology because of incorrect orientation 
and limited sectioning of the specimen (14% in a recent series (116)). Optical diagnosis 
would enable surveillance intervals to be determined immediately after colonoscopy and 
as such would potentially lead to significant time and cost savings. 
Kessler et al (117) performed modeling of real time endoscopy histology followed by 
resection and discarding of <6mm polyps versus resection and submission for 
histology on 4474 consecutive colonoscopies in which 10400 polyps were removed, 
9042 of them less than 6mm (diminutive). They found that at $75 per specimen, at 
least $151 000 could be saved for each 1000 patients with at least one diminutive 
polyp and less than 1 in 1100 patients with diminutive polyp removed would have an 
undetected cancer in any removed polyp. If an assumption is made that 40% of 1.6 
million annual colonoscopies performed in the USA detect at least one diminutive 
polyp, the potential saving from not sending these polyps for histopathological 
assessment is greater than $95 million. Using ‘resect and discard’ policy for 
diminutive polyps would result in annual saving of $33 million when applied to 
colonoscopy screening of the US population (corresponding to overall saving of $330 
million, assuming cumulative period of 10 years to screen just under a quarter of the 
US population) (118). Additional costs are incurred by bringing the patient back for a 
follow up appointment simply to determine the surveillance interval. 
1.4.2 Characterisation	  of	  small	  polyps	  at	  colonoscopy	  
1.4.2.1 White	  light	  colonoscopy	  
Conventional white light endoscopy has been used to attempt to characterize colonic 
polyps, both in still images and in vivo. However, white light colonoscopy has a limited 
accuracy (59-84%) (119-124) in differentiating neoplastic from non-neoplastic polyps 
Figure 4. 
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 No Mean size mm (range) 
Sens % 
 
Spec % 
 
Acc % 
 
Machida 
2004 
43 7.5 
(2-25) 
85.3 44.4 79.1 
Apel 
2006 
273 2.95 93.0 60.0 81.0 
De Palma 
2006 
240 3-4 91.4 68.3 76.3 
Fu 
2004 
206 3-4 88.8 67.4 84.0 
Su 
2006 
110  82.9 
 
80.0 
 
81.8 
Tichendorf 
2007 
100* 10.6 
(2-50) 
63.4 51.9 59.0 
Chiu 
2007 
180 5.33 
(2-20) 
62.1-65.2 85.4-74.4 67.2-68.3 
Figure 4. Sensitivity, specificity and accuracy for small polyp characterisation using conventional 
white light colonoscopy 
 
1.4.2.2 Chromoendoscopy	  
Chromoendoscopy has been in used in Japan to characterise small polyps during 
colonoscopy. By highlighting the shape of the colonic crypts, a pit pattern can be 
seen. Kudo pit-pattern is the most widely used classification system (125). Patterns I 
and II indicate non-neoplastic lesion, IIs, IIL and IV neoplastic lesion and V 
neoplastic lesion with submucosal invasion. This pattern is highly accurate with 
experts achieving accuracy of over 90% for polyp characterisation when using 
magnifying colonoscopes and chromoendoscopy (Figure 12). However, there is an 
appreciable learning curve of 200-300 histologically confirmed lesions to achieve that 
degree of accuracy (126). The extra training, equipment and time required for 
magnifying chromoendoscopy have not made it popular in the West, where it is 
rarely used outside the academic centres. 
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Figure 5. Kudo pit-pattern classification 
 
Figure 6. Type 1 pit-pattern 
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Figure 7. Type 2 pit-pattern 
 
Figure 8. Type 3L pit-pattern 
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Figure 9. Type 3s pit-pattern 
 
 
Figure 10. Type 4 pit-pattern 
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Figure 11. Type 5 pit-pattern 
 
 No of lesions 
Mean size 
mm Sens % Spec % Acc % 
Kato 2006 3438 >5 42.0 98.0 75.0 
Togashi 2006 923 1-11 73.0 92.0 88.0 
Hurlstone 2002 1008 8 92.0 98.0 95.0 
Konishi 2003 405 1-10 93.0 85.0 92.0 
De Palma 2006 240 3-4 97.5 94.3 95.4 
Fu 2006 206 3-4 96.3 93.5 95.6 
Tichendorf 2007 100 10.6 (2-50) 91.7 90.0 91.0 
Chiu 2007 180 5.33 (2-20) 91.3-97.2 74.4-90.5 91.1-92.2 
 
Figure 12. Sensitivity, specificity and accuracy for small polyp characterisation using magnifying 
chromoendoscopy  
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1.4.2.3 Narrow	  band	  imaging	  
Narrow band imaging (NBI; Olympus, Japan (95, 96)) is a new ‘blue light’ optical 
imaging modality available at a push of a button on the colonoscope head. By 
enhancing mucosal detail and in particular vascular structures it allows assessment of 
microvascular density (vascular pattern intensity – VPI (127); meshed brown capillary 
network (128-130). As neoplastic tissue is characterized by increased angiogenesis, 
adenomas appear darker when viewed with NBI. The use of microvascular 
assessment to differentiate between neoplastic and non-neoplastic lesions to have a 
short learning curve (128-130), making it potentially an attractive, practical option for 
optical diagnosis. In previous academic studies, NBI (with and without magnification) 
has been shown to offer similar diagnostic accuracy to magnified chromoendoscopy 
(119, 124, 130-134). 
However only one study, performed by a single expert colonoscopist (135), 
assessed clinical implications of endoscopic diagnosis on surveillance intervals. A 
prospective cohort study on the use of optical diagnosis in routine clinical practice is 
described in Chapter 5. The inter-observer variability of optical diagnosis is 
addressed in Chapter 6. 
Study No of polyps 
Mean 
Size (mm) 
(Range) 
Sens (%) Spec (%) 
Accuracy 
(%) 
Machida 2004 43 7.5 (2-25) 100.0 75.0 93.0 
Su 2006* 110 7.0 (-) 96 88 93 
Chiu 2007* 180 5.3 (2-20) 87-95 72-88 87-90 
East 2007 32 3.4 (2-6) 77-91 50-60 72-81 
Tichendorf 2007 100  9.85 (2-45) 94 90 92 
Sano 2009 150 3.8 (2-10) 96 92 95 
Rastogi 2009 236 4.9 (-) 96 89 93 
Rogart 2009 265 - 80 81 80 
Figure 13. Sensitivity, specificity and accuracy for small polyp characterisation using NBI 
41 
1.5 Reducing	  performance	  gaps	  between	  colonoscopists	  with	  
different	  levels	  of	  expertise	  
Improving inter-observer agreement and reducing performance gaps between 
colonoscopists of different abilities when characterizing small polyps at colonoscopy 
would involve either further training of less experienced colonoscopists or removing 
the element of ‘human error’ entirely by automating the process of optical diagnosis. 
1.5.1 Computer	  aided	  diagnosis	  (CAD)	  
Computer aided diagnosis/detection is a technology that combines elements of 
artificial intelligence and digital processing to result in a software algorithm that 
highlights conspicuous structures. CAD systems are well established in radiology, 
most notably in the mammography and beast cancer screening. Recently, CAD 
algorithms for CT colonography have been developed, helping radiologists to detect 
lesions in the colon. There is little literature on the development of CAD software 
programmes to characterize dysplastic lesions. Chapter 7 describes the 
development of a software algorithm to characterize polyps and report the results 
from the initial experiments and pilot studies. 
1.5.2 Training	  in	  advanced	  endoscopic	  imaging	  
There is emerging literature on the learning curves in colonoscopy. The aim of most 
training programmes is to impart the proficiency with as minimal time and effort 
invested (a ‘steep’ learning curve - Figure 14). However, achieving this does not only 
depend on the complexity of the task and the ability of the trainee, but also the 
structure of the training programme, including the feedback from the trainer. 
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Figure 14. An example of a ‘steep’ learning curve 
 
There is limited evidence on the amount of training required to be able to 
characterize accurately small polyps using advanced endoscopic imaging. 
Chromoendoscopy is thought to have a learning curve of 200-300 histologically 
confirmed polyps (126). As NBI criteria used to classify polyps into neoplastic and non-
neoplastic are simpler then Kudo pit-pattern classification, it is expected that polyp 
characterization using NBI will have a steeper learning curve. A study from Conneticut 
assessed polyp characterization using NBI (131). Four colonoscopists were given 1-
hour interactive lecture and an atlas of NBI images and asked to characterize 265 
consecutive polyps, with feedback given every 2 weeks. The accuracy of polyp 
characterisation improved significantly in the second half of the study (87% vs. 74%, 
p<0.05) suggesting that competency can be reached after 130 polyps. Raghavendra 
et al (136) devised a 20-minute didactic teaching session with an expert colonoscopist 
that used just 35 polyp images and showed that accuracy of polyp characterization 
improved significantly following the training session (90.8% vs. 47.6%, p=0.0001). 
However, didactic teaching sessions are costly and impractical and an online training 
module that could be completed in participant’s own time, not requiring feedback from 
the expert would be an ideal training tool. We have developed a training module on 
the use on use of NBI in characterization of small colonic polyps - its development and 
assessment of construct and content validity are described in Chapter 8. 
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1.5.3 Quality	  assurance	  
Before optical diagnosis could become routine clinical practice, a rigorous system of 
quality assurance would have to be in place to provide objective evidence of 
colonoscopist’s performance. Studies that examined the use of still photographs to 
document caecal intubation at colonoscopy have shown that capturing still 
photographs of caecal landmarks failed to convince some reviewers that complete 
colonoscopy had been performed. In one prospective study videotaping of caecal 
landmarks was considered more convincing than still caecal photographs (137). It 
remains unclear whether still photographs would be adequate evidence that optical 
diagnosis was performed in a satisfactory manner – Chapter 9 explores the reliability 
of still photographs to document optical diagnosis. 
1.6 Hypothesis	  
Can changes in colonoscopic technology improve dysplasia detection and 
characterisation and reduce missed dysplasia and costs associated with 
colonoscopy? 
1.6.1 Lesion	  detection	  
Complete colonoscopy is required in order to maximize surface visualization and 
hence lesion detection. That is possible >95% of cases in expert hands, but some 
colonoscopies are technically challenging even for experts. Magnetic endoscope 
imager (MEI) has been shown to improve colonoscopy completion rates in 
unselected patients but it is unclear if it is of benefit in specific subgroups of patients. 
Aim: To investigate the effect of MEI on colonoscopy completion and adenoma 
detection in patients likely to have technically difficult colonoscopy. 
Narrow band imaging (NBI) highlights superficial mucosal capillaries. As adenomas 
have an increased microvascular meshwork, NBI may therefore help detection of 
subtle lesions. 
Aim: To investigate whether NBI improves detection of dysplastic lesions in patients 
with colitis (using a randomized controlled study) and in those without (meta-analysis 
of randomized studies). 
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1.6.2 Lesion	  characterisation	  
Being able to characterise small colonic polyps in vivo (optical diagnosis) would lead 
to significant time and cost savings associated with colonoscopy. However whether 
that is feasible in routine practice is not clear. 
Aim: To assess whether optical diagnosis is feasible in routine clinical practice using 
a prospective cohort study and to assess inter-observer agreement using 
retrospective data. 
Reducing inter-observer variability in optical diagnosis would either require further 
training of less experienced colonoscopists or automating the procedure by using a 
computer based algorithm. 
Aim: To assess whether a training module on the use of NBI to characterise small 
colonic polyps and a computer algorithm can be developed that would improve the 
accuracy of optical diagnosis for less experienced colonoscopists and therefore 
reduce performance gaps. 
Adequate quality assurance would need to be in place before optical diagnosis could 
become routine clinical practice. 
Aim: To assess if still photographs provide adequate representation of 
colonoscopist’s performance. 
1.6.3 Thesis	  strategy	  
Chapter 1 reviews the aetiology of CRC and the importance of dysplasia detection 
and characterisation at colonoscopy. The evidence base for the current advanced 
colonoscopic techniques and technologies is presented. 
Chapters 2, 3 and 4 focus on dysplasia detection using advanced technology and 
imaging. Chapter 2 investigates whether the use of MEI improves colonoscopy 
completion rates and dysplasia detection in patients likely to have difficult 
colonoscopies and traditionally lower rates of complete colonoscopy and potentially 
more missed dysplasia. Chapters 3 and 4 assess whether NBI improves detection of 
dysplasia in patients with and without colitis. 
Chapter 5 investigates whether optical diagnosis is feasible and safe in routine 
clinical practice. Previous studies have suggested a significant inter-observer 
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variability when characterizing small colonic polyps - the level of inter-observer 
agreement when making optical diagnosis using NBI, chromoendoscopy and AFI is 
explored in Chapter 6. Developing a computer-based algorithm to classify colonic 
polyps would remove the element of human error and potentially decrease 
performance gaps between colonoscopists with different levels of experience. 
Development and validation of such a software algorithm is described in Chapter 7. 
Chapter 8 describes the development and validation of a training module on the use 
of NBI for characterization of small colonic polyps. Learning curve and changes in 
inter-observer agreement are investigated. 
Chapter 9 addresses the issues of quality assurance of optical diagnosis and 
whether the still photographs are representative enough of the colonoscopist’s 
performance. 
Chapter 10 concludes the thesis, drawing together the conclusions from the studies 
performed and suggests further directions for research. 
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Chapter	  2 Does	  ScopeGuide	  improve	  caecal	  
intubation?	  A	  randomized	  controlled	  
trial	  
2.1 Background	  and	  Aims	  
Incomplete colonoscopy, defined as a failure to intubate the caecum, is one 
explanation for missed cancers in the right colon (24, 138, 139). A population based 
cohort study of 12487 patients with CRC reported that 2-5% had a CRC diagnosed 
within 3 years of colonoscopy, with right-sided colorectal cancer associated with 
greatest risk (23). Incomplete colonoscopy is an issue in routine clinical practice with 
several reports of large-scale colonoscopy trials (>5000 colonoscopies) that 
estimated caecal intubation rates to be 77%-87% (29-31). Patients with incomplete 
colonoscopy are more likely to be older, female and have a history of abdominal or 
pelvic surgery (31). 
According to the US Multi-Society Task Force on CRC, caecal intubation rate should 
be ≥90% in all cases and ≥95% in screening cases and be documented by 
visualisation of the ileocaecal valve and appendiceal orifice (26). Although complete 
colonoscopy is possible in more than 95% of cases, it remains at times a technically 
difficult procedure even in expert hands (140, 141). Most difficulties during 
colonoscopy arise from often unpredictable and recurrent looping of the colonoscope 
within the floppy and elastic bowel. The loops not only frequently preclude the 
progression of the examination but also lead to pain for the patients due to stretching 
of the colonic wall and mesenteric attachments (43). In one study 90% of all pain 
episodes coincided with either loping or straightening of the colonoscope shaft (44). 
To achieve complete colonoscopy safely and with least discomfort to the patients 
most loops need to be straightened out with a combination of manoeuvres, including 
anticlockwise/clockwise twist (torque), withdrawal, changing the patient position and 
abdominal hand pressure. This is often done with ‘trial and error’ as it is impossible 
to characterise precisely a type of loop formed at conventional colonoscopy without 
the aid of some imaging. 
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A new technique using a magnetic field to visualise an inserted endoscope was first 
described in 1993 (82). Coils, set at regular distances in the shaft of the colonoscope, 
generate a pulsed low voltage magnetic field and the magnetic impulses are detected 
by sensor coils in a disk external to the patient. Each signal is modified in such a way 
that the three-dimensional view of the colonoscope is obtained which can be viewed 
either in lateral or antero-posterior positions in real time. A comparison between the 
colonoscope position and the endoscopy assistant’s hand applying abdominal 
pressure can be obtained by using a further mobile sensor coil. 
MEI has proved to be of benefit for visualising and removing loops during colonoscopy 
resulting in reduced intubation times and increased completion rates, particularly in 
trainees, in some (83, 86) but not all studies (85). It is unclear whether using MEI 
improves patient tolerance or has any effects on the sedation doses required. 
A number of studies have investigated factors likely to predict technically difficult 
colonoscopy. Women tend to have more difficult procedures and are more prone to 
loop formation, particularly in the transverse colon, probably due to a generally longer 
and more redundant colon as well as the round shape of female pelvis (142, 143). 
Looping also tends to be less well tolerated in women (44). Other variables thought to 
be predictive of difficulty are age over 50 (142), low BMI (<22), past history of 
constipation, and past history of abdominal or pelvic surgery (35, 38, 142, 143). 
Factors thought to be associated with an uncomfortable colonoscopy procedure are 
younger age, low BMI, past history of hysterectomy, symptoms of irritable bowel 
syndrome, longer procedure time (> 480s) and technically difficult procedure (143). 
The aim of this study was to assess whether in a group of patients likely to have a 
technically difficult colonoscopy, MEI: 
1 Improves caeacal intubation rate 
2 Reduces caecal intubation time 
3 Improves patient comfort during the procedure 
4 Improves adenoma detection rates 
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2.2 Methods	  
2.2.1 Participants	  
A score based on factors known to contribute to technically difficult colonoscopy as 
well as anecdotal experience of the senior author (BPS) was devised (Table 3). It 
was assumed that patients who scored 2 or more points would be predicted to have 
a technically difficult colonoscopy. 
Table 3. Factors predictive of a technically difficult colonoscopy 
 Male Female 
 0 1 
Age>55 1 1 
BMI<22 1 1 
Constipation 2 2 
History of abdominal pain 1 1 
Previously difficult colonoscopy 2 2 
Previous abdominal surgery 1 1 
 
Consecutive patients aged >60 who had a positive FOBT as a part of national BCSP 
and were scheduled a colonoscopy at St Mark’s hospital between September 2009 
and July 2010 and who fulfilled the inclusion criteria (score ≥2) were invited to 
participate. Patients were excluded if they were found to have active inflammatory 
bowel disease, previous colonic resection or the caecum could not be reached due 
to poor bowel preparation or an obstructing colonic lesion. Written informed consent 
was obtained and the study was approved by the local research ethics committee 
(08/H0717/44). 
2.2.2 Study	  design	  and	  randomization	  
This was a randomized parallel trial in which patients were randomized in 1:1 ratio to 
a colonoscopy with MEI view available (study group) or without (control group). 
Randomisation results, with stratification according to endoscopist, obtained using a 
computer-generated sequence were kept in sealed opaque envelopes, which were 
opened by the research nurse just before the colonoscopy. 
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2.2.3 Colonoscopic	  protocol	  
Patients were prepared with Senna and 2 sachets of magnesium citrate (Citramag®, 
Sanochemia). Colonoscopies were performed with patients unsedated or under 
conscious sedation using midazolam and pethidine. Patients were given 20mg 
intravenous hyoscine butylbromide at the start of the procedure or on reaching the 
caecum, with additional anti-spasmodic given at the discretion of the endoscopist. All 
procedures were performed by one of three bowel cancer screening accredited 
colonoscopists (BPS, STG, MV), each having completed at least 2000 previous 
colonoscopies (with caecal intubation rate of >95% and adenoma detection rate of 
>50%, personal communication), using conventional CF and CFH 260 series 
variable stiffness instruments and Lucera processors (Olympus Medical System 
Corp., Japan). MEI views were recorded in all examinations, but procedures were 
randomised to take place either with or without the colonoscopists viewing the 
imager display. Patients were intubated to the caecum with appropriate position 
changes and hand pressure as required (86). Caecal intubation was confirmed by 
identification of all three anatomical landmarks: the tri-radiate fold, the ileo-caecal 
valve and the appendiceal orifice. A research assistant recorded the intubation time 
using a stopwatch. 
For those examinations in which colonoscopists were randomised not to see the 
imager view, if advancement of the colonoscope was substantially impaired (>20 
minutes or earlier at the colonoscopist’s discretion) at any time during intubation, it 
was deemed (for ethical reasons) that the colonoscopist should be allowed to view 
the imager display in order to complete the examination. For the purposes of the 
study, those procedures were classified as ‘failed’. 
After each examination the quality of bowel preparation and clinical findings were 
documented. Before leaving the endoscopy unit, patients were asked to record the 
pain experienced during the procedure (as reported by the patient, measured on a 
100 mm visual analogue scale (VAS); 0=none, 100=extremely severe pain). 
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2.2.4 Primary	  and	  secondary	  outcomes	  
The primary outcome measure was caecal intubation time in the study and control 
groups. Secondary outcome measures included: caecal intubation rates, patient pain 
scores and numbers of polyps detected. 
2.2.5 Statistical	  analysis	  
The smallest difference judged to be clinically important was a 5 minute reduction in 
intubation time (SD=5), requiring 22 patients in each group (total 44 patients 
randomized), with a power of 90% (5% significance level). 
Continuous variables were compared using Mann-Whitney test. Unpaired t test was 
used to compare doses of pethidine, midazolam and buscopan. Fisher’s exact test 
was used to analyse categorical data. A two-sided p-value <0.05 was considered to 
be statistically significant. Analysis were done using Stata statistical package 
(version 9.2). This study was reported according to the CONSORT guidelines (144). 
2.3 Results	  
2.3.1 Participants	  
Between September 2009 and July 2010, 430 patients were identified and 59 fulfilled 
the inclusion criteria, of whom 45 were randomized in 1:1 ratio to undergo 
colonoscopy with or without the MEI view available to the colonoscopist. Forty-four 
patients (22 in each arm) completed the study protocol (Figure 15). None of the 
participants experienced complications. 
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Figure 15. Participant flow through the trial 
 
Baseline characteristics of patients recruited were similar for patients examined with 
or without the MEI view (Table 4). 
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Table 4. Baseline characteristics of patients who completed the trial 
 MEI (n=22) No MEI (n=22) 
Mean age, yrs (SD) 67 (4) 67 (4) 
Male, n (%) 2 (9%) 0 (0%) 
Predicted difficulty score, med (IQR) 2 (2-2.75) 2 (2-3) 
History of constipation, n (%) 0 (0%) 0 (0%) 
History of abdominal pain, n (%) 0 (0%) 0 (0%) 
Previous difficult colonoscopy, n (%) 0 (0%) 1 (5%) 
Previous abdominal surgery, n (%) 3 (14%) 3 (14%) 
Previous hysterectomy, n (%) 0 (0%) 1 (5%) 
 
2.3.2 Caecal	  intubation	  rate	  and	  time	  
Intubation to caecum was achieved in 21 of 22 (95%) patients when the MEI view 
was available and 18 of 22 (82%) when it was not available, p=0.35 (Fisher’s exact 
test). In 4 cases the colonoscopist failed to progress, resorting to the MEI view with 
subsequent achievement of caecal intubation. Median time taken to complete 
intubation to the caecum when the MEI view was available was 6.6 minutes (IQR 
4.3-11.1) compared to that when the MEI view was not available, 9.1 minutes (7.4-
13.5) (p=0.07; Mann-Whitney test). 
2.3.3 Patient	  comfort	  levels	  
The median patient pain score in the group when MEI view was available was 4 (IQR 
0-22) compared to 15 (10-25) when MEI view was not available (p=0.03). 
Two patients in the arm where MEI was available and 4 in the other arm opted for 
unsedated colonoscopy. The amount of sedation given during the procedure did not 
differ between patients examined with and without MEI view available (Table 5). 
There was no difference in the number of loops formed whether the MEI was used 
(n=1, IQR 1-2.5) or not (n=1, IQR 1-2) (p=0.38; Mann-Whitney test). 
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Table 5. The amount of sedation used in each arm 
 MEI No MEI P value 
Pethidine, mg, mean (SD) 28.75 (9.16) 27.94 (8.30) 0.78 
Midazolam, mg, mean (SD) 1.31 (0.28) 1.36 (0.33) 0.63 
Buscopan, mg, mean (SD) 13.33 (4.85) 12.5 (4.44) 0.58 
 
2.3.4 Polyp	  detection	  rate	  
In the group where MEI view was available, 33 polyps (21 adenomas) were detected 
compared to the group where MEI view was unavailable (20 polyps, of which 15 
were adenomas), p=0.05. 
2.4 Discussion	  
In the present study, the first to assess the use of MEI in patients likely to have a 
technically difficult colonoscopy and performed by highly experienced 
colonoscopists, although there was a trend to improved caecal intubation rates and 
times when the MEI view was available to the colonoscopists, it did not reach 
statistical significance. These findings are consistent with those reported in the 
literature when experienced colonoscopists perform the procedures in unselected 
patients (85, 145, 146). In contrast, Hoff et al (83) reported improved caecal 
intubation rates for experienced colonoscopists with the use of the MEI. However, 
the number of colonoscopies that defined experienced colonoscopists in that study 
was 200, a number probably too low to describe expertise. This is further supported 
by findings that colonoscopists described as experienced had a suboptimal overall 
caecal intubation rate (84%) with long caecal intubation times, even with the use of 
the imager (19.1 minutes, 95% CI 17.2-21.0). In that study, there was no difference 
in caecal intubation times whether the imager view was available or not, unlike in the 
study reported by Shah et al (86) where for both trainees and skilled colonoscopists 
(>10000 colonoscopies), MEI reduced median intubation times, but only improved 
caecal intubation rates for trainees. Use of MEI is likely to have more impact on the 
colonoscopic performance of trainees than highly experienced colonoscopists, 
although even in our study, the caecal intubation rate without the imager (82%) was 
lower that the regularly audited rates of participating colonoscopists (>93%) and the 
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imager was beneficial in transferring a difficult intubation into a successful one in 
4/22 (18%) patients. Although experienced colonoscopists routinely reach the 
caecum in more than 95% of colonoscopies (12, 147), there is a wide variation in 
caecal intubation rates in the community reported in studies from the UK, USA and 
Canada (77%-81%). Failure to reach the caecum may have considerable 
implications for miss rates of significant dysplastic lesions and cancer and is one 
explanation for poor protection offered by colonoscopy for right-sided colon cancers 
(148). This is further substantiated by the findings that factors predictive of 
technically difficult colonoscopy (female gender, older age, history of diverticular 
disease) are independently associated with missed cancer (diagnosis of colorectal 
cancer within 3 years of colonoscopy) (23). 
Analysis of secondary outcomes revealed that more adenomas were detected in the 
group of patents where the MEI was used although it was not related to the caecal 
intubation rate. It is unclear how the use of the MEI would have contributed to the 
difference in adenoma detection rates and as this study was not powered to detect 
that finding the result should be considered simply as hypothesis generating but 
should be addressed in future work. It is possible that using the MEI allows 
colonoscopists to apply the correct manouvers to resolve loops rapidly, thereby 
avoiding the trial and error approach needed if there is no external imaging available, 
allowing them to concentrate more on mucosal visualization.  
For colonoscopy to be an acceptable screening procedure to patients, the discomfort 
during the procedure should be as minimal as possible. In this study, the use of MEI 
appeared to lead to reduced pain scores reported by the patients (p=0.04), which 
were universally low, despite the use of minimal sedation. This is in contrast to 
findings reported by other studies (44, 84, 85) where the use of MEI was not 
associated with improved pain scores. In our study of technically difficult 
colonoscopies >90% of patients included were women. Failure to reach the caecum 
is more likely in females, who are also more likely to experience pain during the 
procedure (44). Women are more prone to loop formation (41) and tolerate looping 
less well and this may explain the findings of our study.  
This study has a number of limitations. Although the factors predictive of technically 
difficult colonoscopy were identified from the literature, the score for inclusion of 
patients has not been validated and it is unclear whether all patients included were 
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truly likely to have a technically difficult colonoscopy. The score should be validated 
in a prospective study. Although most of the difficulties associated with colonoscopy 
arise from unpredictable and frequent looping of the colonoscope within a floppy 
colon, which can only be resolved with trial and error manouvers without MEI, some 
colonoscopies are challenging due to acute angulations caused by adhesion from 
previous surgery or inflammation. It is unlikely that the MEI would be helpful in the 
latter group of patients, where flexible thinner colonoscopes are more likely to result 
in successful insertion (149, 150). All colonoscopies in this study were performed in 
a tertiary academic unit by highly experienced specialist bowel cancer screening 
accredited colonoscopists with above average caecal intubation and adenoma 
detection rates and fast caecal intubation times (median 8.08 minutes, IQR 6.04-
11.36). Therefore, basing a power calculation on the difference of 5 minutes may 
have been unrealistic as it is unlikely that the imager would have improved intubation 
times by that much in highly experienced endoscopists. Consequently smaller 
difference in caecal intubation times may have been missed by the present study. It 
is likely that MEI would improve caecal intubation times by greater amount in less 
experienced colonoscopists and trainees and this should be addressed in a 
prospective trial. 
In summary, this small study comparing colonoscopy with and without the MEI in 
patients likely to have technically difficult colonoscopy, could not find the difference 
in ceacal intubation rates and times between the two groups that it was powered to 
do. However, type II error cannot be excluded due to overoptimistic power 
calculation and a smaller difference in caecal intubation times may have been 
missed. A prospective multi-centre studies should be performed to validate the 
predicted difficulty score and address whether in patients predicted to have a 
technically difficult colonoscopy use of MEI affects ceacal intubation rates and times, 
patient comfort levels and adenoma detection rates for less experienced 
colonoscopists. 
56 
Chapter	  3 Narrow	  band	  imaging	  for	  detection	  of	  
dysplasia	  in	  colitis:	  a	  randomized	  
controlled	  trial	  
3.1 Background	  and	  Aims	  
Patients with long standing ulcerative colitis (UC) have an increased risk of dysplasia 
and colorectal cancer, with cumulative incidence reported to be 7.7% at 20 years 
and 15.8% at 30 years after the onset of colitis (151). Colonoscopic surveillance of 
these patients has been shown to improve survival from colorectal cancer by 
detecting it at an earlier stage (152) and hence guidelines recommend for it to start 
10 years after the onset of symptoms (112). 
Dysplastic lesions in UC are often flat and subtle and easy to miss with conventional 
colonoscopy as demonstrated by a recent study where 16 out of 30 cancers 
detected during the surveillance programme were interval cancers (151). Therefore, 
most guidelines suggest that, in addition to targeted biopsies, random quadrantic 
biopsies should be taken every 10 cm at surveillance colonoscopy. The use of 
random biopsies originates from a time when endoscopic resolution was much 
poorer than with the modern instruments and it has been proposed that untargeted 
biopsies should be abandoned as each individual biopsy only samples 0.03% of the 
colonic mucosal surface and that time should be spent on closer inspection and dye-
spraying, with a targeted biopsy approach (153). 
Chromoendoscopy has been shown to improve dysplasia detection in colitis (90, 91, 
93), however it is time consuming, increasing the procedure time and even when 
performed with specially designed dye spray catheters, complete and even mucosal 
dye coverage is not guaranteed (66, 89). 
Narrow band imaging (NBI), on the other hand, is easily activated at a push of a 
button and provides complete mucosal enhancement. As the relative contribution of 
red light is decreased, NBI highlights in particular the mucosal vascular pattern. 
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The aim of this prospective multi-centre randomized trial was to compare NBI with 
white light colonoscopy (WLE) for dysplasia detection in patients with long-standing 
colitis who are having surveillance colonoscopies. 
3.2 Methods	  
3.2.1 Participants	  
Consecutive patients with long-standing colitis scheduled for a surveillance 
colonoscopy with one of 4 colonscopists at St Mark’s hospital (JEE, BPS, NS, AI) 
and 2 at Queen’s Medical Centre (KR, VS), between May 2006 and May 2010 were 
invited to participate. The inclusion criteria were an objective diagnosis of left-sided 
or pan-colitis (endoscopic and histological), disease duration >8 years for pan-colitis 
and >10 years for left sided colitis, with evidence of microscopic inflammation at 
previous colonoscopy. Due to slow recruitment, the last inclusion criterium was 
abolished after 40 patients had been recruited. Exclusion criteria were age ≤18 
years, inability or unwillingness to consent to the procedure and severe active colitis 
(endoscopist assessment). All patients gave informed consent and the study was 
approved by the Brent Research Ethics Committee (06/Q0408/10). 
3.2.2 Study	  design	  and	  randomization	  
This was a randomized parallel trial in which patients were randomized in 1:1 ratio to 
a withdrawal with WLE or NBI. Randomisation results obtained using a computer-
generated sequence were kept in sealed opaque envelopes, which were opened by 
the research nurse once the caecum had been reached. 
3.2.3 Colonoscopic	  protocol	  
Patients were prepared with Senna and 2 sachets of magnesium citrate (Citramag®, 
Sanochemia) or 4L of PEG solution (Klean-Prep®, Norgine). Colonoscopies were 
performed with patients unsedated or under conscious sedation using midazolam 
and pethidine. Patients were given 20mg of intravenous hyoscine butylbromide at 
the start of the procedure or on reaching the caecum, with additional anti-spasmodic 
given at the discretion of the endoscopist. WLE was used for intubation in all 
colonoscopies and no biopsies were taken during insertion, although care was taken 
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to wash and suction any residual stool. Caecal intubation was confirmed by 
identification of all three anatomical landmarks: the tri-radiate fold, the ileo-caecal 
valve and the appendiceal orifice. Assessment of bowel preparation was made once 
the caecum was reached: good (only liquid stool present removable with suction), 
adequate (some semi-formed stool obscuring <10% of the mucosa after suction) and 
poor (>10% of the mucosa obscured by solid stool after suction). Patients with poor 
bowel preparation were excluded from the study. 
Colonoscopies were performed using the Olympus Lucera system with a sequential 
RGB filter (CV-260 series, Olympus, Tokyo, Japan) incorporating WLE and NBI. The 
NBI mode was activated by pushing a button on the head of the colonoscope. 
The colon was examined segmentally, with targeted biopsies or definite resection 
(snare polypectomy or endoscopic mucosal resection) of any suspected dysplastic 
lesions. Areas suspicious for dysplasia were defined as any mucosal irregularity, 
stricturing or ulceration not consistent with active or chronic UC as seen with WLE. In 
addition to those, suspicious lesions on NBI were defined as those with increased 
vascular intensity and Kudo pit pattern III-V. The size (measured against open 
biopsy forceps), position (colonic segment), shape (Paris classification) and 
endoscopic diagnosis were recorded for each lesion. Once a lesion was resected, 
quadrantic biopsies from the surrounding mucosa were taken. Targeted biopsies 
were sent to histopathology in a separate pot. In both arms of the study, random, 
non- targeted quadrantic biopsies were taken every 10cm on withdrawal and the 
number of suspicious lesions; number of targeted biopsies and withdrawal times 
were recorded. 
3.2.4 Histopathological	  evaluation	  
Three pathologists, at least one of whom is considered an expert in the field 
assessed all the samples and classified them according to the Vienna classification, 
ranging from no intraepithelial neoplasia to invasive neoplasia (10). The expert 
pathologist provided a second review of all dysplastic lesions. Neoplastic lesions 
were classified as low grade, high grade and invasive neoplasia; those classified as 
indefinite for neoplasia were not considered neoplastic. 
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3.2.5 Primary	  and	  secondary	  outcomes	  
The primary end point of this study was the number of patients with at least one 
dysplastic lesion detected (defined as at least low grade dysplasia). The secondary 
end points were the total numbers and the number of patients with dysplastic, 
suspicious and false positive lesions. 
For conventional white light colonoscopy, based on previous studies (91), we 
assumed the dysplasia detection rate of 7%. With a power (1-β) of 80% and a 
significance level α of 5%, n=220 patients (110 in each arm) were required to detect 
a three-fold difference in the primary end point, from 7% to 21% (based on 
chromoendoscopy studies (90, 93)). The trial was powered for primary outcome 
measure and all others should be considered as exploratory or hypothesis 
generating. 
3.2.6 Statistical	  methods	  
Data were represented by their means (+/- standard deviation) or medians (+ 
interquartile range) as appropriate. Categorical variables were compared using 
Fishers’s exact test. Continuous variables were compared using unpaired t-test or 
Mann-Whitney test as appropriate. Binary outcomes were compared using logistic 
regression. Count variables were compared using Poisson regression, as they could 
not be transferred to a more normal distribution. Outcomes were subsequently 
adjusted for withdrawal time, family history of colorectal cancer and previous history 
of a dysplastic lesion. 
Interim analysis was planned at the halfway point (i.e. 55 in each arm) and if the 
assumptions of the original power calculation were not met the trial would be 
stopped. As the proportion of patients with dysplasia in each arm was identical at the 
half-way point, with the trial size originally powered to detect at least a 3 fold change, 
following statistic advice the trial was stopped. Significant extension of recruitment to 
detect a smaller change was not feasible. 
A two-sided p value of less than 0.05 was considered significant. Analyses were 
done using Stata statistical package, version 9.2 (StataCorp. 2005. Stata Statistical 
Software: Release 9. College Station, TX: StataCorp LP). This study was reported 
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according to the CONSORT guidelines (144) and is registered with 
ClinicalTrials.gov, NCT00292175. 
3.3 Results	  
3.3.1 Participants	  
Between May 2006 and May 2010, 119 patients were identified and fulfilled the 
inclusion criteria, of whom 112 were randomized in 1:1 ratio to undergo extubation with 
WLE or NBI (Figure 16). All 112 patients (56 in each arm) completed the study protocol. 
None of the participants experienced complications. Six experienced colonoscopists 
performed all the procedures, with two performing the majority of colonoscopies (n=88). 
There was no significant difference between the number of white light and NBI 
examinations performed by each of the six colonoscopists (p=0.54). 
 
 
Figure 16. Participant flow through the trial 
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Baseline characteristics for patients who completed the trial are demonstrated in 
Table 6. 
 
Table 6. Baseline characteristics of patients who completed the trial 
 WLE, n=56 NBI, n=56 p-value 
Mean age, yrs (SD) 52 (11) 53 (14) 0.70 
Male, n (%) 31 (55%) 34 (61%) 0.70 
UC duration, yrs, median (IQR) 21 (15-30) 21 (15-28) 0.86 
Withdrawal time, minutes, median 
(IQR) 
10.0 (8.6-12.4) 11.5 (9.5-14.2) 0.01 
Extent of colitis 
Pancolitis (E3) 
Left-sided (E2) 
 
51 
5 
 
45 
11 
 
0.18 
History of dysplasia, n (%) 3 (5%) 6 (11%) 0.49 
History of PSC, n (%) 2 (4%) 2 (4%) 1.00 
Maintenance 5ASA, n (%) 29 (52%) 27 (48%) 0.85 
Maintenance sulphasalazine, n (%) 13 (23%) 12 (21%) 1.00 
Maintenance azathioprine, n (%) 13 (23%) 13 (23%) 1.00 
Family history of CRC 7 (13%) 7 (13%) 1.00 
Bowel preparation 
Good 
Adequate 
 
12 (21%) 
44 (79%) 
 
17 (30%) 
39 (70%) 
 
0.38 
 
3.3.2 Detection	  of	  dysplasia	  in	  targeted	  biopsies	  
The median extubation time for NBI was 11.5 minutes compared to 10 minutes for 
WLE (p=0.01). Thirty-two targeted biopsies were taken during extubation with NBI 
and 16 during withdrawal with WLE. In the NBI arm, there were 17 suspicious 
lesions detected in 13 patients (Table 7, Table 8). Histopathology confirmed 5 
dysplastic lesions in 5 patients (all 5 low-grade dysplasia). Remaining lesions were 
inflammatory (n=7), normal mucosa (n=4) or a hyperplastic polyp (n=1). In the WLE 
arm, 11 suspicious lesions were detected in 8 patients and 7 lesions (in 5 patients) 
were neoplastic (low-grade dysplasia, n=5 and high-grade dysplasia n=2). The false 
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positive lesions were inflammatory (n=1), indefinite for dysplasia (n=1), reactive 
(n=1) and inflammatory (n=1). 
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Table 7. Per patient comparisons of the primary and secondary outcomes 
Number of 
patients with NBI (n=56) WLE (n=56) 
Adjusted OR* 
(95% CI) p-value 
True positive 
lesions 
5 5 0.69 
(0.16, 2.96) 
0.62 
Suspicious lesions 13 8 1.48 
(0.51,4.25) 
0.47 
False positive 
lesions 
8 4 2.01 
(0.53, 7.68) 
0.31 
 
*Adjusted for withdrawal time, family history of CRC and past history of dysplasia 
Table 8. Per lesion comparison between NBI and WLE arms 
Number of 
lesions 
NBI  WLE Adjusted OR 
(95% CI) 
p-value 
True positive 
lesions 
5 7 0.71 
(0.23, 2.25) 
0.57 
Suspicious lesions 17 11 1.55 
(0.72, 3.30) 
0.26 
False positive 
lesions 
12 4 3.00 
(0.97, 9.30) 
0.06 
 
In addition, there was no difference between the two arms when the outcomes were 
adjusted for withdrawal time, family history of colorectal cancer or previous history of 
a dysplastic lesion. 
3.3.3 Detection	  of	  dysplasia	  in	  non-­‐targeted	  random	  biopsies	  
In the NBI arm, 1348 random biopsies were taken (mean per patient, n=25, SD 6.3) 
and histopathology revealed low-grade dysplasia in 1 biopsy (from 1 patient). This 
patient had a dysplastic lesion already detected by targeted biopsies in ascending 
colon (random biopsies detected dysplasia in sigmoid colon). However, no further 
dysplastic lesions were detected in this patient during 4 years of colonoscopic 
surveillance. During withdrawal with WLE, 1359 random biopsies were taken (mean 
per patient, n=24, SD 5.7) and none were found to harbour dysplasia. Yield of 
dysplasia from random non-targeted biopsies was 1/2707 (0.04%). 
64 
3.4 Discussion	  
This is the third randomized, but the first parallel group, multi-centre study comparing 
WLE and NBI for detection of dysplasia in patients with long standing ulcerative colitis. 
The results of this study show that using NBI does not appear to lead to higher 
detection rates of patients with dysplasia compared to WLE (five patients with 
dysplasia detected in both arms). Using NBI appeared to lead to detection of more 
suspicious lesions (17 for NBI vs. 11 for WLE) and although there was a trend for 
more false positive lesions detected in NBI arm (12 vs. 4 for WLE) this was not 
statistically significant. 
This is in agreement with two other studies published on the use of NBI in dysplasia 
detection in UC. Although the other two studies used a different methodology of 
delayed cross over design, they both showed no increase in detection of dysplasia 
when using NBI. The first study (106) attributed the lack of improved detection with 
NBI to the fact that a first generation prototype NBI was used which provided reduced 
light intensity leading to a darker image, insufficient to obtain a good overview of 
mucosal surface. The second study by the same group (154) compared new 
generation NBI with high definition white light colonoscopy and again could not 
demonstrate improved dysplasia detection with NBI. However both of these studies 
found a much higher rate of dysplasia when using white light alone (17-19%) 
compared to dysplasia detection rates found in the older chromoendoscopy studies 
(7.5%) (91). As the inclusion criteria for chromoendoscopy and NBI studies, including 
our own, were similar, this high rate of dysplasia detection is likely to be attributed to 
the improved resolution obtained with modern conventional white light colonoscopy. 
The prevalence of dysplasia in our study of 9% in both arms is more comparable to 
the historical data. Our original inclusion criteria aimed to identify high-risk patients 
more likely to have dysplasia, however due to slow recruitment this inclusion criterium 
was abolished after 40 patients were recruited. Therefore patients finally included in 
the study fulfilled the same criteria as those in previously published studies (106, 154). 
Factors such as duration of the disease, previous history of dysplasia, family history 
of CRC and primary sclerosing cholangitis have been associated with increased risk 
of dysplasia in patients with UC whereas the use of maintenance mesalazine has 
been found to reduce the risk of dysplasia (155, 156). In this study there was no 
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difference between the two arms with regards to increased risk factors for dysplasia 
and furthermore no difference in the primary outcome when data were adjusted for 
withdrawal time, family history of CRC or a previous history of dysplasia. 
Most national guidelines on surveillance colonoscopy for patients with long standing 
ulcerative colitis recommend that quadrantic random biopsies should be taken every 
10cm to improve detection of dysplasia. The most recent guideline from British 
Society of Gastroenterology (112) advises the use of chromoendoscopy with 
targeted biopsies as the preferred method of surveillance although if not available 
the usual random biopsies should be taken. The yield of dysplasia from random non-
targeted biopsies in this study was 0.04% and the only random biopsy that showed 
low grade dysplasia was detected in the patient who already had a dysplastic lesion 
detected with a targeted biopsy. In addition, the long-term outcome of low grade 
dysplasia on a single biopsy in ulcerative colitis is not clear and indeed this patient 
had no further dysplasia detected during 4 years of colonoscopic surveillance. This 
level of dysplasia detection is low enough that serious consideration should be given 
to abandoning non-targeted random biopsies in patients with ulcerative colitis. 
This study has a number of limitations. NBI was compared to white light endoscopy and 
not chromoendoscopy, which many national guidelines now recommend as the gold 
standard surveillance strategy. However the dysplasia detection achieved with white light 
in this study is comparable to that historically achieved when using chromoendoscopy, 
suggesting an effect of improved resolution of standard white light colonoscopy. 
Power calculation for a parallel, randomized controlled trial necessitated inclusion of 
a large number of subjects, but a priori decision was made to stop the trial early if 
assumptions of power calculation were not met. At half-way point there was no 
difference in dysplasia detection between WLE and NBI, with OR 0.69 (95% CI 0.16-
2.96) suggesting that NBI was less likely to detect dysplasia than WLE with 
confidence intervals that were less than 3, which was the basis of original power 
calculation. Further recruitment would have been unlikely to detect the differences as 
specified in the original power calculation, although a smaller difference may have 
been missed. Therefore, although this study was stopped after 112 patients were 
recruited, this still represents the largest study to date on the use of NBI for dysplasia 
detection in UC.  
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Although NBI is unlikely to have a role in dysplasia detection, it may aid lesion 
characterization, when combined with other imaging tools to aid the detection (eg, 
AFI), decreasing the number of false positive findings (157). Other narrow spectrum 
technologies such as FICE and iSCAN have not been formally studied in this setting 
but like NBI are unlikely to lead to improved detection of dysplasia. High definition 
white light may in fact be as good as chromoendoscopy and warrants a formal 
comparative study. 
In conclusion, this, albeit, underpowered study, could not demonstrate improved 
dysplasia detection as specified in the power calculation by using NBI when 
compared to conventional white light colonoscopy. Further work should compare NBI 
with chromoendoscopy for detection of dysplasia using randomised, cross-over, 
back-to-back study design. 
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Chapter	  4 Narrow	  band	  imaging	  for	  detection	  of	  
neoplastic	  and	  non-­‐neoplastic	  lesions	  
in	  the	  colon:	  a	  meta-­‐analysis	  
4.1 Background	  and	  Aims	  
Colonoscopy with polypectomy of adenomas results in 76-90% reduction in expected 
incidence of colorectal cancer (CRC) (11, 12). However, colonoscopy is not fault-
less, with adenoma miss rates of about 22% (95% confidence interval, CI, 15-
32%)(46). Adenoma detection rate has been proposed as one of the quality 
indicators of colonoscopy has been shown to be associated with development of 
interval cancer (59). In addition, 3-5% of patients who develop CRC would have had 
a colonoscopy within the preceding 3-5 years (22, 23) and it appears that 
colonoscopy is protective for left sided cancers but not for right sided ones (148). 
This is likely to be multifactorial but tunour biology of the right sided colorectal 
cancers is thought to be one of the factors. These lesions often arise from relatively 
flat, subtle polyps which often have ‘hyperplastic’ appearance and are known as 
sessile serrated polyps. 
A number of methods to improve adenoma detection rates have been investigated, 
such as changes in patient position (54), wide angle colonoscopy (146), retrograde 
viewing auxillary imaging devices (158) and methods that increase mucosal contrast, 
such as chromoendoscopy (66) and narrow band imaging (NBI). Chromoendoscopy 
improves detection of colonic polyps (87) but is perceived to be time-consuming and 
is not used in routine clinical practice in the UK. NBI, which has been described as 
electronic chromoendoscopy is significantly more ‘user-friendly’ but the data about its 
benefits on polyp detection rates is conflicting, with some (67), but not all studies 
reporting an improvement in adenoma detection rates (68, 97, 99). The aim of this 
study was to perform a meta-analysis of published studies to compare polyp 
detection rates of NBI with conventional colonoscopy. 
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4.2 Methods	  
4.2.1 Study	  selection	  
Published literature was searched using PubMed, Embase, Cochrane database and 
Google Scholar without date restrictions. The following terms were used to search 
PubMed (date of last search 25th May 2011) – Narrow band imaging OR [Narrow band 
imaging and colonoscopy] or [narrow band imaging and endoscopy] OR [Narrow band 
imaging and polyps]. Two reviewers independently screened the titles and abstracts 
and obtained full text articles of the potentially eligible studies. Reference lists of 
theses articles and the personal libraries of the authors were searched for additional 
relevant articles. Only full articles published in English were included. 
2.2.2 Study eligibility 
Randomised controlled trials that compared NBI to WLE for detection of dysplasia 
(adenomas) in the colon were eligible for inclusion. Studies that included patients 
that underwent colonoscopy for screening, surveillance and diagnosis were included; 
those assessing dysplasia detection in ulcerative colitis were excluded. Primary 
outcomes of interest were: 
1 Total number of adenomas detected 
2 Number or proportion of patients with at least one adenoma detected 
3 Mean number of adenomas per patient 
 
Secondary outcomes were: 
1 Total number of diminutive adenomas (<6mm) 
2 Total number of flat/sessile/depressed adenomas 
3 Total number of hyperplastic polyps 
 
In order to be included in the analysis the studies had to compare at least one 
primary outcome measure between NBI and WLE. Studies were excluded if they 
were not parallel arm randomised controlled trials or the outcomes of interest were 
not reported. 
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4.2.2 Data	  extraction	  
Two reviewers independently extracted the data about study characteristics (author, 
year of publication, study design), participants (number of patients, demographics), 
number of endoscopists, withdrawal times for colonoscopy, outcomes (as described 
above), randomization (sequence generation and allocation concealment) and 
sources of bias from each study using a data collection form. The same two 
reviewers assessed methodological quality of the studies using CONSORT checklist 
for reporting a randomized controlled trial. 
4.2.3 Data	  analysis	  
A meta-analysis was performed on the following outcomes: the proportion of patients 
with at least 1 adenoma, the mean number of adenomas per patient, the total 
number of all adenomas, diminutive adenomas, flat adenomas and hyperplastic 
polyps. The odds ratio was used to compare the proportion of patients with detected 
adenomas between NBI and WLE. For the mean number of adenomas detected per 
patient, the pooled weighted mean difference was calculated. Differences in 
detection of all, diminutive and flat adenomas and hyperplastic polyps between NBI 
and WLE were quantified using relative risks. The 95% confidence intervals (CI) 
around relative risks were calculated assuming that the number of detected lesions 
would follow a Poisson distribution. Der Simonian-Laird random-effects model (159) 
was used to take into account differences in sample size between studies. Individual 
and pooled ratios were presented by the use of Forrest plots. Statistical analysis was 
performed using Stata version 9.2 (StataCorp LP, College Station, TX, USA). 
4.3 Results	  
A total of 34 reports on the use of NBI for dysplasia detection in colon were retrieved 
by the search strategy. Twenty-nine articles were reviews, case reports, letters or 
non-randomised trials (102, 133, 134, 160-182). Therefore 5 randomised controlled 
trails were included in the meta-analysis. In addition, a further randomised controlled 
trial from our group (in press) is included. Flow chart of articles selected from the 
search is shown in Figure 17. 
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Figure 17. Flow chart of articles selected 
 
Six large randomized, parallel arm, controlled trials have been performed that 
directly compared NBI with WLE for detection of adenomas (67, 68, 97-99, 183). 
Table 9 lists all included studies and their characteristics. 
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Table 9. Characteristics of the studies included in the meta-analysis  
Author 
and 
year 
Number of 
patients 
Sex of 
patients 
Male (%) 
Age, mean 
(SD) Patient 
population Endoscopists 
NBI WLE NBI WLE NBI WLE 
Rex 
2007 217 217 51% 55% 62 (8) 63 (9) 
Routine 
colonoscopy 
aged >50, 
without known 
polyposis or 
IBD, intact 
colons 
1 experienced 
colonoscopist 
Adler 
2009 625 631 47% 48% 64 (7) 64 (7) 
Routine 
colonoscopy, 
adult patients 
without known 
IBD or CRC, 
intact colons 
7 colonoscopists 
(each >500 
colonoscopies) 
Adler 
2008 200 201 58% 48% 
59 
(13) 
60 
(14) 
Asymptomatic 
patients, 
screening 
colonoscopy, 
aged >55 
6 experienced 
colonoscopists 
(mean 19800 
colonoscopies) 
Paggi 
2009 103 108 54% 57% 60 (5) 61 (6) 
Routine 
colonoscopies, 
aged 50-69, 
positive FOBT 
6 colonoscopists 
(2 >500 
colonoscopies 
each, 4 >5000 
colonoscopies 
each) 
Inoue 
2008 122 121 63% 60% 
63 
(11) 
61 
(14) 
Routine 
colonoscopies, 
adult patients, 
without known 
polyposis, IBD 
or CRC,  
6 (unknown 
experience) with 
1 colonoscopist 
performing 
>60% of all 
procedures 
East 
2010 108 106 51% 70% 64 (9) 65 (9) 
Routine 
colonoscopies, 
adult patients, 
without known 
polyposis or 
IBD, intact 
colons 
3 colonoscopists 
(>1000 
colonoscopies 
each), with 1 
performing 
>50% of al 
procedures 
 
 
All six studies were prospective randomized parallel group trials and used 
colonoscopes from Olympus Corporation (Tokyo, Japan) but two (97, 183) used 
Lucera processors available in the Japan and the UK while the remainder used Exera 
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processors. Four studies used high-definition systems (67, 98, 99, 183) and wide-
angled 170° colonoscopies (67, 68, 98, 99). All six studies used slightly different study 
populations but were reasonably well matched for patient demographics. 
4.3.1 Primary	  outcomes	  
Total number of adenomas detected 
There were 2314 adenomas detected in 2759 patients in the six studies and were 
included in the analysis. A study by Inoue et al (97) was the only one that 
demonstrated a significantly improved detection of adenomas by NBI versus WLE 
(total number of adenomas, 102 vs. 65, p=0.046). However in this study inadequate 
allocation method meant that one colonoscopist who performed most of the 
colonoscopies was more often allocated to NBI. Therefore the difference observed 
may be due to the experience of this single colonoscopist. The pooled results of all 
studies revealed a non-significant increase in total number of adenomas when NBI 
was used for detection (RR 1.08, 95% CI 0.95-1.22) Figure 18. 
 
Figure 18. Forrest plot. Total number of adenomas detected 
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Patients with at least one adenoma detected 
All six studies were included in the analysis. No individual studies revealed that NBI 
significantly improved detection of adenomas on per patient basis and therefore the 
pooled analysis showed a non-significant increase in patients with at least 1 
adenoma when NBI was used for detection (OR 1.11, 95% CI 0.93-1.31) (Figure 19). 
 
Figure 19. Forrest plot. Number of patients with ≥ 1 adenoma detected. 
 
Mean number of adenomas per patient 
Four studies involving 1260 patients were included in the analysis as standard 
deviation around the mean could be extracted from the paper. The pooled weighted 
mean difference in the number of adenomas detected was 0.08 (95% CI -0.05-0.20, 
p=0.24) in favour of NBI. 
4.3.2 Secondary	  outcomes	  
Not all studies provided data on detection of hyperplastic polyps, diminutive and flat 
adenomas. 
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Detection of hyperplastic polyps 
Four studies (68, 97, 99, 183) provided data on the number of hyperplastic polyps 
detected. Two of the studies showed significantly improved detection of hyperplastic 
polyps with NBI and, similarly, pooled results revealed a significant increase in the 
number of hyperplastic polyps detected with NBI compared to WLE (RR 1.75, 95% CI 
1.10-2.79). 
Detection of diminutive and flat/sessile/depressed adenomas 
Four studies (67, 97, 98, 183) involving 1102 patients provided data on the total 
number of diminutive (≤5 mm) adenomas detected. There were no difference 
between NBI and WLE for the detection of diminutive adenomas (RR 1.10, 95% CI 
0.88-1.36). Five studies reported detection of flat/sessile/depressed adenomas (68, 
97-99, 183) in 2325 patients. Again, there was no difference in detection of these 
lesions when using NBI compared to WLE (RR 1.40, 95% CI 0.73-2.71). However, 
the lack of significance for this outcome is mainly due to the biggest study included 
(99) which behaved differently to the other studies (Figure 20). 
 
Figure 20. Forrest plot. Detection of flat/sessile/depressed adenomas. 
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4.4 Discussion	  
With increasing emphasis placed on quality assurance of colonoscopy with the aim 
of reducing the miss rates for adenomas and the risk of subsequent interval CRC, a 
potential role for novel technologies has been investigated. Chromoendoscopy has 
been shown to improve detection of small and flat adenomas (65, 66, 88) but is too 
time consuming and labour intensive to be implemented in routine clinical practice 
(184). NBI is thought to be an alternative to chromoendoscopy, which may be more 
convenient and cost-effective. However, only one study (97) revealed an improved 
adenoma detection rate with NBI. In this study, more than 60% of colonoscopies 
were performed by one colonoscopist and inadequate allocation of NBI 
colonoscopies raised concerns of bias in this study. The other 5 studies and the 
pooled results showed no difference in the adenoma detection with NBI when 
compared with WLE, when analysed either on per lesions or per patient basis. 
Similarly, pooled results for all six studies showed no difference in detection of 
diminutive adenomas between NBI and WLE. 
NBI would be expected to improve the detection of flat and sessile adenomas by 
enhancing mucosal contrast. Again no significant difference was observed between 
NBI and WLE, although one of the studies, contributing the largest number of patients 
for analysis, behaved quite differently to the others without clear explanation. 
Four studies addressed the detection of hyperplastic polyps and pooled results 
revealed that NBI on average detected 75% more hyperplastic polyps that the white 
light. This is unsurprising as hyperplastic polyps are often subtle and NBI should lead 
to improved mucosal contrast and hence easier detection. This is of interest as one 
of the explanations for missed lesions in the right colon is their appearance and 
biology through sessile serrated pathway of carcinogenesis. Sessile serrated lesions 
are often flat or sessile and have appearance of large hyperplastic polyps. In addition 
a new syndrome of hyperplastic polyposis has recently been recognized which is 
thought to be associated with increased risk of developing CRC. This is defined as 
the presence of at least 30 hyperplastic polyps in the pancolonic distribution or five 
hyperplastic polyps proximal to the sigmoid with at least two >10mm (9). Hence the 
importance of being able to detect hyperplastic polyps, especially proximal to the 
recto-sigmoid, should not be underestimated. 
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As with any meta-analysis there are possible limitations when combining individual 
studies. Colonoscopy is operator dependent and all studies used a different number 
of colonoscopists with varying levels of experience. The operator experience, 
including the interpretation of the findings, as well as differences in colonoscopic 
techniques and adenoma detection rates are likely to have contributed to some 
heterogeneity within the meta-analysis. All studies were prospective randomised 
trials although the method of randomization was not clear in one of the studies (97) 
and that of allocation in 4 others (68, 97-99). 
In conclusion, NBI does not improve the detection of adenomas when compared to 
WLE but it may improve the detection of hyperplastic polyps. Prospective randomised 
studies looking at long term outcomes, such as missed or interval cancers are 
required to ascertain the clinical significance of NBI in terms of lesion detection. 
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Chapter	  5 In-­‐vivo	  characterization	  of	  dysplasia	  
5.1 Background	  and	  Aims	  
More than 90% of polyps detected at colonoscopy are small (6-9 mm) or diminutive 
(≤5mm), with the latter making up the majority (107-109). Approximately 50% of 
small polyps are non-neoplastic (109, 110) and therefore a large number of 
polypectomies are performed unnecessarily, increasing the risks of the procedure. 
Even small polyps, with little risk of harboring cancer, are currently sent for histology 
as the number of adenomas is one of the best determinants of long term cancer risk 
and allows an informed decision on future surveillance intervals (26, 112, 113). An 
ability to correctly diagnose a polyp during colonoscopy (optical diagnosis) would 
allow for recto-sigmoid hyperplastic polyps to be left in situ and for small adenomas 
to be resected and discarded without a need to retrieve the polyp for formal 
histopathology and potentially leading to significant time and cost savings. 
Conventional white light colonoscopy has a limited accuracy (59-84%) (119-124) in 
differentiating neoplastic from non-neoplastic polyps. Application of dyes 
(chromoendoscopy) with optical magnification and pit pattern recognition in expert 
hands provides very accurate optical diagnosis (85-95.6%) (121-123, 185, 186) 
however there are major drawbacks to this approach in terms of time, cost and the 
learning curve to achieve expertise. Narrow band imaging (NBI; Olympus, Japan (95, 
96)) is a new ‘blue light’ optical imaging modality available at a push of a button on 
the colonoscope head. By enhancing mucosal detail and in particular vascular 
structures it allows assessment of microvascular density (vascular pattern intensity – 
VPI (127). As neoplastic tissue is characterized by increased angiogenesis, 
adenomas appear darker when viewed with NBI. The use of microvascular 
assessment appears to have a short learning curve (128-130), making it potentially 
an attractive, practical option for optical diagnosis. In previous academic studies, NBI 
(with and without magnification) has been shown to offer similar diagnostic accuracy 
to magnified chromoendoscopy (119, 124, 130-134). However only one study, 
performed by a single expert colonoscopist (135), assessed clinical implications of 
endoscopic diagnosis on surveillance intervals. 
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DISCARD was a prospective, cohort study aimed to assess whether diagnosis of 
small polyps using simple, widely available optical techniques and in particular non-
magnifying NBI, is feasible and safe in routine clinical practice. 
5.2 Methods	  
5.2.1 Patients	  
Consecutive patients who were referred for a surveillance colonoscopy (adenoma 
follow up, but not a polyposis syndrome) or who were positive on faecal occult blood 
testing (FOBT), between August 2008 and June 2009, were invited to participate in 
this prospective study at St Mark’s Hospital, London, United Kingdom. Experts 
mainly examined high risk, FOBT positive patients as a part of the national bowel 
cancer screening programme and non-experts performed more routine surveillance 
colonoscopies. All patients had a standard bowel preparation using magnesium 
citrate (Citramag; Pharmaserve, Manchester, England) and senna. Patients with 
poor bowel preparation (semi-solid stool that could not be suctioned or washed away 
and less than 90% of surface seen (187)) were excluded. Additional exclusion 
criteria were: presence of an obvious cancer or only polyps ≥ 10mm, absence of 
polyps or polyps seen but not retrieved or an optical diagnosis made. Written 
informed consent was obtained from all patients. The study protocol was approved 
by the local review board (Harrow REC 05/Q0405/121). 
5.2.2 Procedures	  
Four colonoscopists performed the procedures. Two were expert colonoscopists and 
had previously performed >10000 colonoscopies with experience of NBI in >1000 
cases, one was a trainee (<500 colonoscopies, <50 NBI examinations) and one a 
specialist nurse, (>3000 colonoscopies, <10 NBI colonoscopies). Experts and non-
experts were not present for the same procedures. All were familiar with the vascular 
pattern intensity classification, and non-experienced endoscopists completed a 
training session with feedback from an expert on the use of NBI in characterizing 
polyps, using a library of images of 20 polyps collected as a part of a previous study. 
High definition (1080 horizontal lines of resolution when used with an HD monitor) 
non-magnifying Olympus CF-H260DL colonoscopes with Lucera video processors 
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(Olympus, Japan) were used for all the procedures. Chromoendoscopy was 
performed by ‘flooding’ the polyp with 10ml of (0.1%) indigo carmine through the 
biopsy port of the colonoscope followed by mucosal inspection and freeze-framing 
optimal images for pit pattern analysis. 
When a polyp < 10mm was encountered the location, size and shape according to 
Paris classification (188) were recorded. Size was estimated using biopsy forceps 
(2.2 mm closed, Radial Jaw 3, Boston Scientific) or mini snare (10mm diameter, 
Oval snare, Olympus). Endoscopists were asked to predict a polyp type 
(hyperplastic, adenoma, carcinoma, other) using high-definition (HD) white light and 
if unable to make an optical diagnosis with white light, NBI was activated by pushing 
the button on the head of colonoscope. The polyp was assessed in vivo with both 
real time and optimized freeze frame NBI images. Polyps were classified by 
assessment of vascular pattern intensity (adenomas have stronger VPI compared to 
non-neoplastic polyps which have the same or lighter VPI) (Fig 1). If colonoscopists 
were still unable to confidently predict the histology, chromoendoscopy was used. In 
our experience, NBI assessment typically takes a few seconds and 
chromoendoscopy about a minute, provided that the indigo carmine is drawn up and 
ready for application. 
Polyps in which optical diagnosis was made with low confidence (that is, even though 
optical diagnosis may have been made, colonoscopists elected to resect and 
electively send them for formal histopathology) and failure to make an optical 
diagnosis after chromoendoscopy resulted in “no optical diagnosis” being recorded 
and polyp would have been sent electively for histopathology even if a policy of optical 
diagnosis were implemented. In addition to prediction of histopathology, a decision on 
polyp management made by colonoscopists, based on optical diagnosis was 
recorded; whether they would resect and discard the polyp (no formal histopathology), 
resect and send it for histopathology (if they could not decide on the type of polyp or 
were concerned about malignancy), or leave it in situ (for diminutive recto-sigmoid 
non-neoplastic lesions). Where possible a surveillance interval recommendation 
based on the optical diagnosis was recorded at the end of the procedure (British 
Society for Gastroenterology, BSG, guidelines – no surveillance or 5 years for 1 or 2 
adenomas <10mm; 3 year surveillance for 3-4 small adenomas or at least one ≥10mm 
and 1 year surveillance if ≥5 adenomas or ≥3 if at least one ≥10mm (112)). All polyps 
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were biopsied or resected and sent for histopathological assessment, each polyp in a 
separate pot. The reference standard was histopathology using standard 
haematoxylin and eosin staining of at least six cut levels. Experienced gastrointestinal 
histopathologists, who were blinded to endoscopic images and optical predictions, 
classified all specimens according to World Health Organization (WHO) guidelines 
(189). Surveillance intervals recommended following optical diagnosis were compared 
to those following histopathology. 
5.2.3 Statistical	  analysis	  
The primary outcome was accuracy of optical diagnosis in differentiating between 
adenomas and non-neoplastic polyps. Assuming accuracy of optical diagnosis to be 
93% (for polyps which endoscopists would have resected and discarded, i.e. no 
formal histopathology) and to lie within confidence interval ±3%, a total of 278 polyps 
needed to be prospectively assessed (with 95% confidence level). Fisher’s exact test 
was used to compare categorical variables. A two-sided p value < 0.05 was 
considered statistically significant. Subgroup analysis was performed to look at the 
effect of polyp size (6-9mm vs. ≤5mm) and endoscopists’ experience on the primary 
outcome. Analysis were done using Stata statistical package (version 9.2). This 
study was reported according to the STROBE guidelines (190) 
5.3 Results	  
Two hundred and eighty patients were invited to participate in the study, of whom 
130 were included (Figure 21, Table 10). There were 363 polyps <10mm resected 
from 130 patients (≤ 5mm, n=296; 6-9mm, n=67). No completely flat or depressed 
lesions (Paris IIb or IIc lesions) were found. Optical diagnosis was not attempted in 3 
polyps (all ≤5mm) and not made with high confidence in a further 37 polyps, with 
colonoscopists electively choosing to send polyps for formal histopathology (17 
hyperplastic, 16 adenoma, 3 destroyed by diathermy, 2 not retrieved and 2 reported 
as normal mucosa). All hyperplastic polyps electively sent for histology were located 
in the proximal colon. 
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Figure 21. Flow diagram of participants through the study 
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Table 10. Demographics of participants 
Demographics  
Mean (SD) age, y 63.4 (10.6) 
Sex, no (%)  
Male 87 (66.9%) 
Female 43 (33.1%) 
No of patients who had a previous 
colonoscopy 70 (53.8%) 
No of patients undergoing first colonoscopy 60 (46.2%) 
Indication for colonoscopy, n (%)  
FOBT + 32 (24.6%) 
History of polyps  68 (52.3%) 
History of CRC 1 (0.7%) 
Family history of CRC  14 (10.8%) 
Change in bowel habit 15 (11.5%) 
Mean (SD) polyp size, mm 3.7 (2.04) 
Shape  
Is 317 
IIa 43 
Ip 3 
Polyp location  
Caecum 52 (14%) 
Ascending colon 42 (12%) 
Transverse colon 148 (41%) 
Descending colon 29 (8%) 
Sigmoid colon 44 (12%) 
Rectum 48 (13%) 
 
 
Non-expert colonoscopists assessed 104 polyps in 64 patients and experts 259 
polyps in 66 patients, reflecting the fact that experts examined patients that were 
more likely to have greater number of polyps. Optical diagnosis was made with high 
confidence (a colonoscopist prepared to resect and discard a polyp or leave it in situ) 
in 323 polyps (non- experts, n=87 and experts, n=236). Overall, colonoscopists 
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made a decision to resect and discard 290 polyps and leave 33 in situ. For the 
purposes of the study all polyps were resected and submitted for histopathology. All 
polyps which colonoscopists would have left in situ were correctly predicted to be 
hyperplastic polyps and were all located in the sigmoid colon or the rectum. Of those 
polyps where optical diagnosis was made, 39 were not retrieved and 6 fragmented 
during pathology processing, leaving 278 polyps with both optical and 
histopathological diagnosis. Of those there were 198 adenomas (187 low grade 
dysplasia, 3 high grade dysplasia and 8 villous) and 80 non-neoplastic lesions (62 
hyperplastic polyps, 15 normal mucosa and 3 serrated lesions without dysplasia). 
Colonoscopists predicted correctly all 3 serrated lesions as non-neoplastic and 
elected to resect and discard them as their location was in the proximal colon. There 
were a total of 14 high-risk lesions (high grade dysplasia or villous components) - 11 
would have been resected and discarded and 3 resected and sent for formal 
histopathology using optical diagnosis. 
Overall, 186/198 (0.94, 95% CI 0.90, 0.97) of adenomas (sensitivity) and 55/62 
(0.89, 95% CI 0.78, 0.95) of hyperplastic polyps (specificity) were correctly 
diagnosed by optical diagnosis using white light alone or in combination with NBI and 
chromoendoscopy, giving an accuracy of 241/260 (0.93, 95% CI 0.89, 0.96) for polyp 
characterisation using optical diagnosis. Colonoscopists correctly diagnosed 68/198 
(34%) of adenomas and 20/62 (32%) non-neoplastic lesions using white light alone. 
A combination of white light and NBI was used to reach an optical diagnosis for the 
remaining polyps apart from in 3 polyps (1 adenoma and 2 hyperplastic) where 
chromoendoscopy was used in addition 
Sensitivity and specificity, positive and negative predictive values, and accuracy are 
detailed in Table 11. Expert colonoscopists were more accurate than non-experts in 
optical diagnosis of adenomas (136/141 (96%) vs. 50/57 (88%); p=0.04, Fisher’s 
exact test) and overall accuracy (95% vs. 87%, p=0.03; Fisher’s exact test). 
There was no difference in the accuracy of optical diagnosis when polyps were 
assessed according to size (≤5mm vs. 6-9mm; Table 12). More high-risk lesions 
(HGD and villous adenomas) were found in polyps 6-9mm than those ≤5mm (7/67 
vs. 7/296, p=0.006; Fisher’s exact test). Endoscopists chose to resect and send for 
elective histopathology (low confidence optical diagnosis) 15/67 (22%) of polyps 6-
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9mm in size compared to 22/293 (8%) of polyps ≤5mm (in 3 polyps ≤5mm optical 
diagnosis was not attempted) (p=0.001; Fisher’s exact test). 
Table 11. Per-polyp analysis for polyps for which both optical and histological diagnoses were 
available  
 Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
PPV 
(95% CI) 
NPV 
(95% CI) 
Accuracy 
(95% CI) 
Overall 186/198 
0.94 
(0.90-0.97) 
55/62 
0.89 
(0.78-0.95) 
186/193 
0.96 
(0.92-0.98) 
55/67 
0.82 
(0.70-0.90) 
241/260 
0.93 
(0.90-0.96) 
Experts 136/141 
0.96 
(0.91-0.99) 
38/42 
0.90 
(0.76-0.97) 
136/140 
0.97 
(0.92-0.99) 
38/43 
0.88 
(0.74-0.96) 
174/183 
0.95 
(0.92-0.98) 
Non-
experts 
50/57 
0.88 
(0.76-0.95) 
17/20 
0.85 
(0.61-0.96) 
50/53 
0.94 
(0.83-0.99) 
17/24 
0.71 
(0.49-0.87) 
67/77 
0.87 
(0.78-0.93) 
 
Table 12. Differences in diagnosis according to polyp size 
 Polyps ≤ 5 mm, 
n=296 
N (%) 
Polyps 6-9 mm, 
n=67 
N, (%) 
p -
value 
Optical diagnosis made 271 (92%) 52 (78%) 0.02 
Polyps not retrieved 37 (13%) 4 (6%) 0.22 
Histology reported as ‘normal’, n (%) 26 (9%) 0 (0%) 0.001 
Correct diagnosis, n (%)    
Adenomas (Sensitivity) 144/155 (93%) 42/43 (98%) 0.46 
Hyperplastic polyps (Specificity) 51/58 (88%) 4/4 (100%) 1 
Accuracy 92% 98% 0.21 
 
 
Optical diagnosis was incorrect in 19 polyps -12 histologically confirmed adenomas 
were endoscopically diagnosed as hyperplastic polyps and 7 histologically confirmed 
hyperplastic polyps were mistakenly predicted to be adenomas. 
There were 14 advanced adenomas detected in this study, all of which were 
diagnosed as adenomas using optical means. Eleven of these high-risk lesions (3 
high grade dysplasia, 1 villous and 7 tubulovillous) in 7 patients would have been 
resected and discarded using optical diagnosis. Two patients with high-risk lesions 
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also had polyps >10mm in size and were therefore excluded from analysis of the 
impact of optical diagnosis on surveillance intervals as per protocol in this study. In 
the remaining 5 patients with 9 advanced polyps, optical diagnosis would have 
resulted in an increase in surveillance interval from 3 years to 5-10 years in 3 
patients according to the US, but not the British guidelines (Table 13, Figure 22). 
Table 13. Two patients with discrepancies between follow-up between optical and histological 
diagnosis (BSG Guidelines) 
Patient 
Surveillance interval 
after optical 
diagnosis (yrs) 
Colonoscopy 
findings 
 
Surveillance 
interval after 
histopathology (yrs) 
Histopathology 
findings 
 
1 1 
5 adenomas 
 
3 
4 adenomas 
1 non-diagnostic 
2 3 3 adenomas 5 
2 adenomas 
1 hyperplastic  
 
Table 14. Surveillance intervals in patients with high-risk lesions using optical diagnosis and formal 
histopathology 
Patient No of adenomas 
No of high risk 
lesions 
Surveillance 
interval using 
optical 
diagnosis* 
(yrs) 
Surveillance 
interval after 
histopathology* 
(yrs) 
1 6 5 3 3 
2 1 1 5 -10 3 
3 4 1 3 3 
4 1 1 5 -10 3 
5 1 1 5 -10 3 
 
 
A recommendation for follow up colonoscopy could be made based on optical 
diagnosis in 82 patients. In the remaining patients (n=48), a surveillance interval 
could not be given due to the following reasons; polyps >10mm were found in 
addition to those <10mm (n=17), polyps were not retrieved (n=15) or could not be 
processed due to diathermy artifact (n=6) or a confident optical diagnosis was not 
made (n=10). The surveillance intervals based on available histopathology and 
optical diagnosis, using BSG guidelines, were identical in 80/82 patients (98%). Two 
patients would have had a longer interval recommended following histopathology 
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(Table 13). There was no difference between experts and non-experts in the 
accuracy of surveillance interval prediction (36/37 (97%) vs. 44/45 (98%), p=1; 
Fisher’s exact test). 
Using US multi-society colonoscopic surveillance guidelines 3/82 patients would have 
had a follow up colonoscopy sooner using formal histopathology (3 years) compared 
to optical diagnosis (5-10 years), with one patient having longer follow up on the basis 
of histopathology (Table 14, Figure 18 Surveillance intervals using optical and 
histopathological diagnosis). Therefore surveillance intervals based on optical 
diagnosis would have been identical using either guideline in 78/82 patients (95%). 
 
Figure 22. Surveillance intervals using optical and histopathological diagnosis 
 
Cost of histopathology for 363 polyps was £7623 (≈$12500) (histology cost per 
polyp, £21, United Kingdom National Tariff 2008/09, Department of Health). Optical 
diagnosis was possible in 323 polyps and would have reduced the cost of 
histopathology by £6783 (≈$11000). Eighty-two patients would have been given an 
immediate surveillance interval following colonoscopy, reducing the cost of clinic 
appointments from £9760 (≈$16000) to £3200 (≈$5300) (cost of routine 
gastroenterology clinic follow-up appointment £80, United Kingdom National Tariff 
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2008/09). Using a policy of optical diagnosis would have resulted in an overall saving 
of £13343 (≈$22000) or 77% for the group of 130 patients examined in this study. 
5.4 Discussion	  
DISCARD was a prospective study showing that optical diagnosis at colonoscopy for 
small colonic polyps is feasible and safe in routine clinical practice. Even though 
there was a wide variation in experience, the colonoscopists in this study, would 
have been confident to rely on optical diagnosis alone in a high percentage of small 
polyps (89%) and the optical assessments were shown to provide accurate 
information for future surveillance intervals. 
In the USA alone some 14 million colonoscopies are performed annually (1). The 
majority of these are for bowel cancer screening where detection and resection of all 
neoplastic polyps is the primary aim. Polyps are detected in approximately 40% of 
screening colonoscopies and over 90% are small or diminutive lesions with perhaps 
as many as 50% of these being non-neoplastic. Current practice mandates resection 
of all polyps with attempted polyp retrieval for histopathological assessment. This is 
both a time and resource-consuming process and results in an inevitable delay in 
providing patients with advice about future surveillance intervals. Also small recto-
sigmoid hyperplastic polyps with no malignant potential could potentially be left in 
situ following optical assessment saving patients the attendant risks of polypectomy. 
The potential cost savings of not sending diminutive polyps for formal histopathology 
are thought to exceed $95 million dollars per year in the USA alone (117). Optical 
diagnosis, in vivo, at the time of colonoscopy is therefore an attractive concept for 
physicians, patients and health care providers as the management pathway is 
potentially streamlined and costs reduced. In this study using simple cost analysis 
we estimate that optical diagnosis would have resulted in approximately 77% cost 
savings for polyp analysis and clinic follow up, which amounts to nearly $22000 for 
the 130 patients examined. Full economic modeling would be needed to assess the 
overall cost savings, taking into account missed polyps and those that were not 
diagnosed correctly (12 adenomas and 7 hyperplastic polyps in this study). Also the 
costs of dealing with a larger or more advanced lesion (a rare event) that might occur 
due to inadvertent over-long surveillance intervals would need to be factored in. 
Capital costs of new endoscopic equipment that can provide NBI images at centers 
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which do not have NBI at present, and the need for NBI training, may initially slow 
widespread clinical adoption; however the business case for adoption of this 
equipment would seem to be strong given the potential cost savings for high volume 
centers. Furthermore, the short learning curve for NBI microvessel based 
classification seen in most studies supports early adoption even outside academic 
centres (128, 129). As the NBI is available in most new generation video processors 
from Olympus, majority of endoscopy units upgrading their equipment are likely to 
have access to NBI or another form of narrowed spectrum endoscopy (FICE, 
Fujinon; I-Scan, Pentax) in the near future at no extra cost. As NBI equipment and 
experience becomes widespread, the concept that NBI-based optical diagnosis for 
small colonic polyps is seen as an acceptable standard of care in routine non-
academic practice seems possible. 
For optical diagnosis to become routine practice it must have an acceptable level of 
accuracy, be quick and easy to perform and provide a permanent record of each 
lesion for quality assurance purposes. Overall accuracy for optical diagnosis in this 
study was 93% (with 6% of adenomas incorrectly diagnosed), which in clinical 
practice is comparable to the overall diagnostic yield for “standard” histopathology. 
This similarity in overall diagnostic yield reflects that with optical diagnosis, a result 
can be potentially be given for every polyp detected; however, small polyps may not 
be successfully retrieved, or may be unsuitable for histological analysis due to 
diathermy artifact (7-19% in large Austrian and UK series (114, 115)). They may also 
be “misclassified” at standard histopathology due to incorrect orientation and limited 
sectioning of the specimen. In one recent series 14% of small polyps were 
reclassified after multiple repeat sections were taken (191). Therefore in the current 
study, although 12 adenomas were incorrectly characterized by optical diagnosis as 
hyperplastic polyps, the impact of histologically misclassified polyps at “standard” 
histopathology, added to those that were lost or destroyed before histopathology, 
may be of a similar magnitude. Diminutive, low risk adenomas on a per lesion basis 
have a very small risk of developing into an invasive cancer (192). Their main 
importance is that if they are multiple (≥3), this predicts increased future colorectal 
cancer risk (113). This difference in multiplicity only affected surveillance intervals in 
2% of optical diagnosis cases using British (BSG) guidelines which use adenoma 
size and multiplicity as the main determinants of surveillance interval. 
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The DISCARD policy has already been proposed as a safe option for diminutive 
polyps, ≤ 5mm, which very rarely contain high-grade dysplasia or villous elements 
(135). However accurate optical diagnosis may be easier in slightly larger polyps and 
we therefore decided to include all polyps <10mm. Our results show a high level of 
accuracy for all polyp sizes although not unsurprisingly more 6-9mm polyps overall 
would have been sent electively for histopathology (22% vs. 9% for polyps ≤5mm) 
where the endoscopist was either unsure of the type of polyp or was concerned over 
the possibility of more advanced pathology. Therefore in practice, even with a policy 
of optical diagnosis, flat depressed lesions, those with distorted morphology and 
hyperplastic-appearing polyps in the proximal colon which may be sessile serrated 
lesions (9, 193), of any size, will usually still be sent for formal histopathology. The 
role of optical diagnosis, therefore, is to reduce the current volume of histopathology 
by diagnosis and treatment of many obvious small benign-appearing adenomas and 
recto-sigmoid hyperplastic polyps seen at routine colonoscopy. 
An important feature in the design of this study was the inclusion of colonoscopists 
with different levels of experience. The bias introduced by different patient 
populations examined by experts and non-experts is likely only to have contributed 
to a difference in polyp detection rate but not accuracy of polyp characterisation 
between experts and non-experts. Expert colonoscopists achieved accuracy of 95% 
for optical diagnosis, a figure similar to that achieved by a single expert in the only 
other study to report on clinical implications of endoscopic interpretation of polyp 
histology (135). However, even non-expert colonoscopists achieved an acceptable 
accuracy of 87% for optical diagnosis a figure comparable to that of community 
pathologists when differentiating adenomas from hyperplastic polyps (194). 
Therefore this approach does appear acceptable across a range of different 
experience levels. The method of optical diagnosis is clearly important and must be 
quick and easy to perform. Chromoendoscopy, the traditional method of optical 
diagnosis, has been popularized in Japan and relies on interpretation of pit pattern 
after vital staining. This technique is highly accurate in expert hands (121, 123-125) 
however it has not been taken on by Western endoscopists, partly because of the 
long learning curve to achieve acceptable accuracy of 200-300 histologically 
confirmed polyps (1, 125, 126) but also because the method is time-consuming and 
necessitates use of magnifying endoscopes which have a relatively long rigid tip 
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section making colonoscope insertion technically more difficult in some patients. 
Conversely, NBI or “electronic dye spray” can be rapidly deployed at a button push 
and provides information on both pit pattern and vascular surface structures. Simple 
interpretation of vascular pattern intensity or the “brown hue” of neoplastic lesions 
compared to the background mucosa appears to be as accurate in differentiating 
neoplastic from non-neoplastic polyps when compared to pit pattern assessment and 
to be easier to learn, with an improvement in diagnostic accuracy after as few as 60 
polyps (127-129). In this study, NBI using vascular pattern intensity and always 
preceded by white light was the most used method (70%) for achieving a confident 
optical diagnosis after white light and was used equally by experts and non-experts 
whilst chromoendoscopy, which, although not formally timed, takes longer to 
perform, was only used for 5 polyps. Our experience therefore suggests that NBI, 
available on all new Lucera processors sold in UK, when used after white light is the 
optimal current method for achieving a rapid in vivo optical diagnosis for most small 
polyps. 
Ultimately the main clinical endpoint of a screening colonoscopy is accurate 
assessment of each patient’s future cancer risk with the ability to give accurate 
advice on screening intervals. In this study, optical diagnosis would have allowed 
82/130 (63%) patients with polyps to be given a follow up colonoscopy date 
immediately after the procedure, representing a potential saving of £9760 (≈$16000) 
in follow up clinic appointments. BSG guidelines on polyp surveillance differ from 
other National society guidelines in that they rely purely on size and number of 
adenomas, the two most important and universally identified factors in risk 
stratification (195, 196). They do not take into account severity of dysplasia or 
degree of villous component, which have also been identified as predictors of 
adenoma recurrence in some but not all studies (113, 195) and which are prone to 
pathologists inter-observer disagreement - in one study of community 
histopathologists only 47% of high-grade dysplasia was diagnosed correctly (194). 
This has made BSG guidelines easy to follow for clinicians but also makes optical 
diagnosis possible as number and size of adenomas can be assessed in vivo, as 
demonstrated in this paper. With refinement of optical techniques it may be possible 
in the future to assess the degree of dysplasia of each individual polyp perhaps by 
recording the intensity of vascular change using NBI as demonstrated by Katagiri et 
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al (197) and this could be made easier for the clinician by image analysis software 
linked to computer-aided diagnosis (198). Being able to accurately characterize the 
degree of dysplasia or villous components using optical diagnosis would enable a 
‘discard policy’ to be adopted in countries where surveillance guidelines use those 
features in risk stratification (26). Our findings show that according to BSG guidelines 
only two patients would have been given a different surveillance interval following 
formal histopathology and no patient would have had a longer than recommended 
surveillance interval based on optical diagnosis when compared to histopathology. In 
addition there was no difference between experts and non-experts in the accuracy of 
predicted surveillance interval. These results are similar to those reported by a 
previous US study, where all colonoscopies were done by a single expert, which 
found that only 1/136 patients received different surveillance intervals when 
recommendations based on endoscopic and pathological diagnosis were compared 
(135). The overall concordance between optical and histopathological determination 
of surveillance interval in our study was slightly less good when using criteria from 
US multi-society colonoscopic surveillance guidelines (95% vs. 98% when using 
British guidelines). This reflects the use of advanced histopathological features as 
additional criteria to determine surveillance intervals in these guidelines although it is 
unknown whether US or British guidelines provide more effective or safer long-term 
cancer prevention. 
This study has a number of limitations. Although four colonoscopists with different 
levels of experience were included in the study, it was set in the academic training 
unit, making it difficult to extrapolate the results to colonoscopists outside of 
specialist units. Similarly the equipment used in this study (Lucera, Olympus Tokyo, 
Japan) is only available in Japan and the UK although the recent studies of polyp 
characterisation using Exera processors available in the USA and continental 
Europe have demonstrated high accuracy (135, 176, 199), comparable to that 
reported in the studies using Lucera processors. 
In summary, we have shown that optical diagnosis, mainly using high definition white 
light and non-magnified NBI, is highly accurate for characterisation of polyps <1cm in 
size. 
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Chapter	  6 Inter-­‐observer	  agreement	  in	  
characterisation	  of	  dysplasia	  
6.1 Background	  and	  Aims	  
Conventional white light colonoscopy (WLE) has been reported to have a limited 
diagnostic accuracy (59-84%) (119-124) in distinguishing adenomas from 
hyperplastic polyps. Addition of chromoendoscopy with pit pattern assessment, 
especially when used with high magnification, increases diagnostic accuracy (85-
96%) (121-123, 185, 186, 200, 201) with good to very good inter-observer 
agreement (0.78-0.96) (124, 202); however chromoendoscopy has not proved 
popular with Western endoscopists for polyp differentiation, partly because of the 
long learning curve to achieve acceptable accuracy of 200-300 histologically 
confirmed polyps (125, 126), but also the perceived labour intensity required. 
Narrow band imaging (NBI) is an optical modality that is easily activated by the push 
of a button on the endoscope head. By enhancing the mucosal detail and in 
particular the superficial vascular structures, NBI allows an assessment of 
microvascular density (vascular pattern intensity – VPI (127), meshed brown 
capillary network) to differentiate between adenomas (more vascular, leading to 
‘strong’ VPI) and hyperplastic polyps (‘normal’ or ‘weak’ VPI) and has been shown to 
offer similar diagnostic accuracy to magnified chromoendoscopic assessments (119, 
121, 124, 130-134, 203). The use of microvascular assessments appears to have a 
short learning curve, with an improvement in diagnostic accuracy after as few as 60 
polyps (129) making it potentially an attractive, practical option for optical diagnosis 
(127, 128, 130, 134). 
An alternative imaging technique also available to endoscopists at a button push is 
autofluorescence imaging (AFI, Olympus, Japan) where adenomas appear magenta 
in colour and hyperplastic polyps green. Although developed as a “red flag” 
technique AFI may be useful in characterisation of small colonic polyps, with one 
recent study reporting sensitivity, specificity and accuracy of 97%, 56% and 74% 
respectively in experienced colonoscopists (204). 
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The last chapter demonstrated that optical diagnosis using NBI was feasible in routine 
clinical practice but inter-observer variability was not assessed. The aim of this study 
was to compare the inter-observer agreement and diagnostic accuracy of WLE with, 
commercially available, electronic imaging techniques, NBI, NBI with magnification 
(NBImag), and AFI to the current gold standard, histopathology, in characterisation of 
small (<10mm) colonic polyps in expert and non-expert Western endoscopists. 
6.2 Methods	  
6.2.1 Images	  and	  observers	  
Polyp images were collected prospectively at St Mark’s Hospital between February 
2006 and August 2008, as part of a ‘Randomised trial of NBI for adenoma detection’ 
(ClinicalTrials.gov identifier: NCT00279357). Data were compared with 
histopathology as the reference standard. Ethical approval was obtained from the 
local review board (Harrow REC 05/Q0405/121) and all patients gave written 
informed consent. 
Each polyp detected was washed to remove mucus and stool, examined and recorded 
from the same endoscopic position in standard definition digital format using WLE, AFI 
and NBI with and without magnification. High-definition monitors (1080 horizontal lines 
of resolution) and colonoscopes capable of optical magnification up to 105 times 
(XCF-H240FZL/I and CF-H260AZL video colonoscopes, XCLV-260HP xenon light 
source and XCV-260HP video system center; Olympus, Japan. NBI filters: blue, 
centred on 415nm; green, centred on 540nm) were used for all procedures. Polyp size 
was estimated using biopsy forceps (2.2mm closed, Radial Jaw3, Boston Scientific, 
Natick, Massachusetts). Polyp morphology was described according to the Paris 
classification (188). All polyps were biopsied or resected and sent for histopathological 
assessment. The reference standard was histopathology using standard haematoxylin 
and eosin staining of at least six cut levels. An experienced gastrointestinal 
histopathologist classified all specimens according to World Health Organisation 
(WHO) guidelines (189). The histopathologist was blinded to the endoscopic 
assessment. Polyps >10mm in size were not included in the study as at present formal 
histopathology is likely to be always required for these lesions. A research fellow not 
involved in image reading selected still images of 80 polyps smaller than 10mm (40 
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adenomas and 40 hyperplastic) with known histology and recorded in WLE, AFI, NBI 
and NBImag (total images=320). Only polyps that had still photographs of good quality 
in all 4 modalities were selected. Without any form of post processing, these images, 
which were of the same size and resolution, were then incorporated into a slideshow 
(one polyp image per slide) (Microsoft PowerPoint 2004 for Mac; Microsoft, Redmond, 
WA). These 320 slides were then arranged at random using a computer generated 
random number sequence and were viewed on standard-definition computer monitor. 
Nine experienced UK gastroenterologists with an interest in advanced colonoscopic 
techniques, four of whom are considered experts on colonic polyp characterisation 
using advanced endoscopic imaging and had published widely on the subject, 
evaluated 320 images. The ‘non-expert’ group consisted of experienced 
colonoscopists but with limited knowledge on the use of advanced imaging in the 
colon. Before starting the study, the non-expert group completed a teaching session 
on polyp characterisation using advanced imaging techniques. A set of twenty polyps 
seen in all four modalities, with explanations on the advanced imaging techniques, 
were incorporated into PowerPoint presentation used for teaching. Additional 
questions raised were answered by a research fellow, with experience in NBI and AFI 
and not involved in the study. Using NBI adenomas typically have stronger VPI and 
hyperplastic polyps weak or same VPI as the background mucosa (127, 130). When 
using AFI, neoplastic areas appear magenta and non-neoplastic green. To avoid bias, 
observers were blinded to the lesion location and histopathological diagnosis. 
6.2.2 Evaluation	  of	  images	  
320 images were shown in random order at a single viewing session. The observers 
were asked to document the overall quality of the image on a 5-point scale (1 best; 5 
worst) and were asked to make a clinical decision on the likely histology of the polyp 
(adenoma vs. hyperplastic polyp). Cases where observers were not certain of the 
diagnosis were treated as incorrect. For NBImag images, the observers were asked 
to record VPI and Kudo pit pattern. 
6.2.3 Statistical	  analysis	  
The primary outcome measure was sensitivity of NBImag compared to WLE in 
differentiating adenomas from hyperplastic polyps. For a power (1-β) of at least 80% 
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with a two-sided significance level (α) of 0.05, 40 adenomas and 40 hyperplastic 
polyps were needed to detect a difference in sensitivity from 75% using WLE to 90% 
using NBImag. The analysis of sensitivity was restricted to true positive cases 
(neoplastic = adenomas), of specificity to true negative cases (non-neoplastic = 
hyperplastic polyps) and all cases were used for the analysis of accuracy. Fisher’s 
exact test was used to compare the results and where there were multiple 
comparisons, p values were adjusted (Bonferroni correction). The strength of 
agreement between observers was assessed using the kappa statistic. The chi-square 
test for trend was used to examine the association of image quality with accuracy. 
Data are reported according to STARD and QUADAS guidelines (205, 206). 
6.3 Results	  
6.3.1 Patient	  and	  Polyp	  Characteristics	  
WLE, NBI, NBImag and AFI digital images of 40 hyperplastic polyps and 40 
adenomas from 48 patients (30 males) were assessed, mean age 64.7 (Standard 
deviation (92) 8.5). Mean polyp size was 4.5mm (SD 3.1). There were 47 sessile 
(Paris 0-Is), 29 flat (Paris 0-II) and 4 pedunculated (Paris Ip) lesions. All adenomas 
contained low-grade dysplasia only and sessile serrated adenomas were excluded 
from this study. 
6.3.2 Image	  quality	  
NBImag images were in general considered to be of the best quality: there was a 
significant difference in mean image qualities between the four modalities, best 
quality lowest, WLE, 2.4 (0.7); NBI, 3.5 (1.0); NBImag, 1.9 (0.9); AFI, 2.7 (0.8); 
p<0.001. 
6.3.3 Inter-­‐observer	  agreement	  for	  polyp	  histology	  
For prediction of polyp histology, the level of agreement between observers was 
similar for all four modalities, with kappa values in the range of 0.4-0.6 indicating 
moderate agreement (Table 15). NBImag was the only advanced imaging modality 
that led to a significantly better agreement for predicting polyp type in the expert 
group (substantial), compared to the non-expert group (moderate) (κ=0.63 vs 
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κ=0.30, p<0.001). The overall kappa value for inter-observer agreement for VPI was 
k=0.62 and there was no difference in inter-observer agreement between expert and 
non-expert colonoscopists (0.69, 0.58-0.80 vs. 0.57, 0.47-0.66, p=0.08). 
6.3.4 Accuracy	  for	  prediction	  of	  polyp	  histology	  
The accuracy for prediction of polyp histology varied across modalities, from 53-76% 
for experts and 32-61% for non-expert colonoscopists (Table 16, Table 17). NBImag 
was the only advanced imaging modality that had a higher sensitivity and overall 
accuracy compared to WLE for both expert and non-expert groups whereas 
specificity and accuracy of AFI were lower compared WLE for both expert and non-
experts (Tables 18 and 19). 
Table 15. Inter-observer agreement among expert and non-expert endoscopists when characterizing 
small polyps using still images obtained with WLE, AFI, NBI and NBimag  
Inter-observer 
agreement 
WLE (κ) 
(95% CI) 
AFI (κ) 
(95% CI) 
NBI (κ) 
(95% CI) 
NBImag (κ) 
(95% CI) 
All observers 0.41 
(0.36, 0.46) 
0.48 
(0.41, 0.55) 
0.49 
(0.44, 0.54) 
0.44 
(0.40, 0.48) 
Experts 0.41 
(0.30, 0.52) 
0.48 
(0.34, 0.61) 
0.48 
(0.37, 0.59) 
0.63 
(0.53, 0.72) 
Non-experts 0.43 
(0.31, 0.55) 
0.52 
(0.34, 0.71) 
0.48 
(0.37, 0.59) 
0.30 
(0.22, 0.37) 
 
Table 16. Sensitivity, specificity and accuracy of WLE, AFI, NBI and NBImag for expert 
colonoscopists (n=4)  
Modality Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Accuracy 
(95% CI) 
WLE 0.69 (110/160) 
(0.61, 0.76) 
0.60 (96/160) 
(0.52, 0.68) 
0.64 (206/320) 
(0.59, 0.70) 
AFI 0.63 (100/160) 
(0.55, 0.70) 
0.43 (69/160) 
(0.35, 0.51) 
0.53 (169/320) 
(0.47, 0.58) 
NBI 0.74 (119/160) 
(0.67,0.81) 
0.56 (90/160) 
(0.48, 0.64) 
0.65 (209/320) 
(0.60, 0.71) 
NBImag 0.93 (149/160) 
(0.88, 0.97) 
0.59 (95/160) 
(0.51, 0.67) 
0.76 (244/320) 
(0.71, 0.81) 
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Table 17. Sensitivity, specificity and accuracy of WLE, AFI, NBI and NBImag for non-expert 
colonoscopists (n=5) 
Modality Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Accuracy 
(95% CI) 
WLE 0.52 (104/200) 
(0.45, 0.59) 
0.29 (57/200) 
(0.22,0.35) 
0.40 (161/400) 
(0.35, 0.45) 
AFI 0.57 (113/200) 
(0.49, 0.63) 
0.07 (13/200) 
(0.04, 0.11) 
0.32 (126/400) 
(0.27, 0.36) 
NBI 0.61 (121/200) 
(0.53,0.67) 
0.32 (63/200) 
(0.25, 0.38) 
0.46 (184/400) 
(0.401, 0.51) 
NBImag 0.90 (179/200) 
(0.84, 0.93) 
0.33 (65/200) 
(0.26, 0.39) 
0.61 (244/400) 
(0.56, 0.66) 
 
Table 18. Sensitivity, specificity and accuracy of AFI, NBI and NBImag when compared to WLE for 
expert colonoscopists (n=4, Paired exact test, all p values Bonferroni adjusted)  
 WLE AFI 
(p-value, 
Bonferroni 
adjusted) 
NBI 
(p-value, 
Bonferroni 
adjusted) 
NBimag 
(p-value, 
Bonferroni 
adjusted) 
Sensitivity 0.69 0.63 
(p=0.71) 
0.74 
(p=0.53) 
0.93 
(p<0.001) 
Specificity 0.60 0.43 
(p=0.001) 
0.56 
(p=1.00) 
0.59 
(p=1.00) 
Accuracy 0.64 0.53 
(p=0.002) 
0.65 
(p=1.00) 
0.76 
(p<0.001) 
 
Table 19. Sensitivity, specificity and accuracy of AFI, NBI and NBImag when compared to WLE for 
non-expert colonoscopists (n=5, Paired exact test, all p values Bonferroni adjusted)  
 WLE AFI 
(p-value, 
Bonferroni 
adjusted) 
NBI 
(p-value, 
Bonferroni 
adjusted) 
NBimag 
(p-value, 
Bonferroni 
adjusted) 
Sensitivity 0.52 0.57 
(p=1.00) 
0.61 
(p=0.13) 
0.90 
(p<0.001) 
Specificity 0.29 0.07 
(p<0.001) 
0.32 
(p=1.00) 
0.33 
(p=1.00) 
Accuracy 0.40 0.32 
(p=0.02) 
0.46 
(p=0.10) 
0.61 
(p<0.001) 
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Table 20. Exact observations for NBImag and WLE, for experts and non-experts  
Group Type WLE result NBImag result 
   Correct Incorrect 
Experts Adenoma Correct 106 4 
(n=4)  Incorrect 43 7 
 Hyperplastic Correct 73 23 
  Incorrect 22 42 
 All Correct 179 27 
  Incorrect 65 49 
Non-Experts  Adenoma Correct 96 8 
(n=5)  Incorrect 83 13 
 Hyperplastic Correct 26 31 
  Incorrect 39 104 
 All Correct 122 39 
  Incorrect 122 117 
 
6.4 Discussion	  
This study directly assesses and compares inter-observer agreement and accuracy 
for small colonic polyps for white light, NBI, NBImag and AFI in colonoscopists with 
different levels of experience. These imaging modalities can be introduced at a quick 
button push, making them user-friendly and potentially acceptable for optical 
diagnosis in routine clinical practice. An ability to diagnose small hyperplastic polyps 
in vivo would avoid unnecessary polypectomies and the attendant time, cost and 
associated risk (207). 
Strengths of this study include its multi-centre design, the inclusion of a large number 
of both expert and non-expert endoscopists (n=9), and the similar number of 
neoplastic and non-neoplastic polyps included, reflecting their relative prevalence in 
clinical practice in this polyp size category. 
When compared to WLE, NBImag was the only advanced imaging modality that, for 
both expert and non-expert colonoscopists, significantly improved both the sensitivity 
(93% vs 68%, p<0.001 for experts and 90% vs. 52%, p<0.001, for non-experts) and 
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overall accuracy (76% vs. 64%, p=0.003 for experts and 61% vs. 40%, p<0.001 for 
non-experts) of small polyp characterisation. In addition, NBImag images were 
reported to be of the best quality (661/698, 95%) and there was a significant 
association between image quality and accuracy of the diagnosis (p<0.001). 
Clinically, this may be of particular relevance to training and accreditation of 
colonoscopists as the ability to take a good quality image is a prerequisite for 
accurate optical diagnosis (208). 
A high inter-observer agreement between all colonoscopists is required if optical 
diagnosis is to become acceptable in routine clinical practice. In this study, there was 
no difference in the overall inter-observer agreement between different modalities, 
with κ in the range 0.4-0.6 (moderate agreement) although using NBImag, experts 
had ‘good’ (k=0.63) compared to non-experts who only had ‘fair’ (k=0.30) inter-
observer agreement. The agreement for all other modalities was ‘moderate’ for both 
groups of colonoscopists, findings that are consistent with published inter-observer 
studies for colonic polyps and for diagnosing histology in Barrett’s oesophagus (133, 
209) where the addition of alternative imaging modalities to WLE did not improve 
yield of neoplasia or inter-observer agreement. The overall level of agreement is 
lower than reported by Japanese endoscopists, but consistent with a previous study 
from a western centre (127). 
Previous academic studies of NBI imaging with and without magnification had a high 
diagnostic accuracy for differentiation of neoplastic from non-neoplastic polyps (119, 
121, 124, 130, 133, 210). Diagnostic accuracy of NBImag in the current study when 
used by experts (76%) is lower than previously reported and probably not high 
enough to be acceptable for in vivo diagnosis. 
However this study has a number of limitations, which may explain this discrepancy. 
Only polyps less than 10mm were included and some studies have shown that the 
accuracy in differentiating adenomas from hyperplastic polyps decreases with 
decreasing polyp size (211). Like previous retrospective inter-observer studies, 
endoscopic still images were used instead of videos. This does not allow for 
assessment of polyps on high-definition monitors from different distances and angles 
available in clinical practice and probably leads to an underestimate of diagnostic 
sensitivity and accuracy, but is a practical way of assessing four-way inter-observer 
agreement. Compared to prospective studies of diagnostic accuracy, endoscopists in 
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the current study were blinded to the colonic location of polyps and any clinical 
diagnostic advantage that may yield. 
In conclusion, this study demonstrates that using magnification with NBI improves 
the inter-observer agreement in expert colonoscopists and accuracy of polyp 
characterisation for all colonoscopists, albeit below the level acceptable for ‘optical 
diagnosis’ during colonoscopy. In addition, NBImag images were deemed to be of 
the best quality suggesting that it may be the optimal advanced imaging modality for 
optical diagnosis in vivo. 
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Chapter	  7 Development	  of	  computer	  algorithm	  
to	  aid	  in	  characterization	  of	  colonic	  
dysplasia	  
7.1 Background	  and	  Aims	  
Accurate diagnosis of adenomas at the time of colonoscopy would improve efficiency 
and patient experience by enabling immediate polyp surveillance planning without 
the need for histopathological confirmation or additional clinic appointments (207). 
White light endoscopy alone is generally considered insufficient for accurate 
characterisation of small colonic polyps (124, 131, 210). Chromoendoscopy with pit 
pattern assessment improves accuracy but is time consuming, a particular problem 
for Western countries where an appreciable 200-300 lesion learning curve is 
encountered(126) . Consequently, there has been considerable interest in narrow 
band imaging (NBI) which highlights superficial microvascular patterns. NBI can be 
used to differentiate adenomas with increased number and colour intensity (brown) 
of microvessels when compared to hyperplastic polyps, which have similar (lighter) 
vascular intensity and hence colour to background mucosa. 
Experienced colonoscopists have a high accuracy of polyp characterisation when using 
narrow band imaging (NBI)(130, 135, 207) but non-experts are likely to be significantly 
less accurate. In addition, studies have shown that when characterising small colonic 
polyps using still images there is appreciable inter-observer variability (203) Chapter 6: 
Inter-observer agreement in characterisation of dysplasia. Inter-observer agreement 
appears to be worse for non-expert than expert colonoscopists. An image processing 
algorithm, which exploits the visual characteristics of the polyp to classify it into one of 
the two categories may reduce intra- and inter-observer variability and narrow the 
performance gap between colonoscopists of different experience levels. 
The purpose of this study was to develop a computer-based algorithm to differentiate 
adenomas from hyperplastic polyps, by exploiting the features that reflect clinically 
observed differences in the strength of vascularity and colour between these two 
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types of polyps. This study is part of a larger program of research developing an 
automatic detection and classification device for endoscopy (Scope-AidTM). 
7.2 Methods	  
A library of still images of polyps viewed with NBI and optical magnification were 
collected prospectively at St Mark’s Hospital between February 2006 and August 
2008, as part of a ‘Randomised trial of NBI for adenoma detection’ (ClinicalTrials.gov 
identifier: NCT00279357). Olympus CF-H260AZL colonoscopes with Lucera video 
processors were used for all colonoscopy examinations. Polyp size was estimated 
using biopsy forceps (2.2 mm closed, Radial Jaw 3, Boston Scientific, USA). Data 
were compared with histopathology as the reference standard. The 62 best quality 
images in which both polyps and the background mucosa were in focus were 
selected for image analysis. Detailed methodology of design and construction of 
computer algorithm has been described in technical reports (212, 213) and is briefly 
summarised here. The resulting algorithm was then externally validated on 118 
Exera images (courtesy Dr D. Rex). 
7.2.1 Construction	  of	  the	  algorithm	  
The polyp border was delineated (manual polyp segmentation) by an experienced 
endoscopist. All images were then converted to grayscale where each pixel is 
characterised by the degree of luminance (‘brightness’). Vectors were used to reflect 
magnitude and direction of change of luminence between neighbouring pixels 
(‘orientation dominance’) and orientation and magnitude of these vectors were 
expressed by generating ‘dominance complex field’ using an optical image analysis 
technique (wavelet filtering). 
7.2.1.1 Feature	  construction:	  use	  of	  orientation	  dominance	  on	  the	  surface	  of	  
the	  polyp	  
To quantify the differences in vascular intensity between adenomas and hyperplastic 
polyps, a histogram of the mean values of magnitude of orientation dominance, 
normalised for the number of pixels on the surface of the polyp, was generated for 
both adenomas and hyperplastic polyps (Figure 23 and Figure 24). 
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Figure 23. The differences between histograms were then exploited to construct the features for 
discrimination between the two types of polyps  
 
 
 
Figure 24. Orientation dominance fields for adenomatous and hyperplastic polyps 
 
7.2.1.2 Feature	  Construction:	  Difference	  of	  orientation	  dominance	  between	  
the	  surface	  of	  the	  polyp	  and	  the	  surrounding	  normal	  mucosa	  
When vascular intensity of the polyp is assessed using NBI, it is often compared to 
the background mucosa. Therefore a feature that quantifies the difference in 
vascularity between the polyp and its background mucosa was constructed. Again, 
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mean normalised histograms of the magnitude of orientation dominance were 
computed for all polyps and their surrounding background mucosa (Figure 25). 
 
Figure 25. Mean normalised cumulative histograms of polyps and surrounding normal mucosa 
 
Kolmogorov-Smirnof statistic was used to compare the two mean histograms and hence 
construct a feature that can be used to discriminate between the two types of polyps. 
7.2.1.3 Feature	  Construction:	  Difference	  of	  colour	  between	  the	  surface	  of	  the	  
polyp	  and	  the	  surrounding	  normal	  mucosa.	  
Colour is routinely used in clinical practice to distinguish between an adenoma and a 
hyperplastic polyp (where adenomas appear more ‘brown’ than the background 
mucosa when viewed with NBI) and can be used as a feature in the classification 
algorithm. As colour is defined in terms of hue and saturation, normalised mean 
histograms for both of these variables were constructed for each polyp and the 
background mucosa. The clinically recognised ‘brown’ colour characteristic of 
adenomas can be mathematically described in terms of hue and saturation values as 
determined by Fisher criterion (Figure 26). 
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Figure 26. Identifying the area of the colour chart that best discriminates between the two types of polyp. 
7.2.1.4 Classification	  Process	  
Fisher Linear Discriminant Analysis was used for the purpose of classification. A 
‘leave one out’ method was used to train the classifier and estimate the correct 
classification rate. Therefore the classification process was repeated 56 times, each 
time using 55 images to train the classifier and the remaining image to test it. The 
overall results represent an average classification rate for 56 images. 
Following manual segmentation, the algorithm takes a few seconds to classify the 
polyp. We assessed polyp classification performance using the three features 
separately first and then using a combination of all to assess whether different 
features are complementary to each other. 
7.2.1.5 External	  validation	  
The same classification process was applied to 118 NBI images of polyps obtained 
using Exera system (Olympus America) (images courtesy of Dr. D. Rex). 
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7.3 Results	  
7.3.1 Lucera	  images	  
56 polyp images (from 49 patients) were selected from the library of images. Mean 
polyp diameter was 4.5 mm (standard deviation 3.1 mm). On histological examination, 
38 polyps were low-grade tubular adenomas and 18 hyperplastic polyps. 
When features were analysed separately, using the strength of vascularity resulted 
in highest sensitivity and overall accuracy. Table 21 shows results for feature 1 
(strength of vascularity of a polyp), feature 2 (difference in strength of vascularity 
between a polyp and the background mucosa) and feature 3 (difference in colour 
between a polyp and the background mucosa). Combining all features together in 
the algorithm resulted in correct diagnosis of 53/56 polyps. One adenoma was 
incorrectly diagnosed as a hyperplastic polyp and 2 hyperplastic polyps were 
incorrectly diagnosed as adenomas. 
Based on classification parameters, a receiver-operator curve (ROC) was generated 
(Figure 27). Combining all features resulted in largest area under the curve 
(AUC=0.91), indicating improved classification performance of the algorithm, with 
sensitivity of 0.97 and specificity of 0.89. 
Table 21. Sensitivity, specificity and accuracy of Scope-AidTM (Lucera images) 
 Sensitivity, % 
(95% CI) 
Specificity, % 
(95% CI) 
Accuracy, % 
(95% CI) 
Features describing strength of 
vascularity of a polyp 
35/38 
92.1 (79.2-97.3) 
13/18 
72.2 (52.2-86.1) 
48/56 
85.7 (74.9-92.3) 
Features describing difference 
in strength of vascularity 
between a polyp and the 
surrounding normal mucosa 
30/38 
79.0 (63.7-88.9) 
14/18 
77.8 (58.0-90.0) 
44/56 
78.6 (66.9-87.0) 
Features describing difference 
in colour between a polyp and 
the surrounding normal 
mucosa 
37/38 
97.4 (86.2-99.9) 
9/18 
50.0 (26.0-74.0) 
46/56 
82.1 (69.6-91.1) 
All features: 37/38 
97.4 (86.2-99.9) 
16/18 
88.9 (65.3-98.6) 
53/56 
94.6 (85.0-98.9) 
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Figure 27. ROC curve generated by using features separately and combined for Lucera images 
7.3.2 Exera	  images	  
118 polyp NBI images were selected of which 59 were adenomas (all low grade 
dysplasia) and 59 hyperplastic polyps. All polyps were <10 mm in size. Sensitivity, 
specificity and accuracy of ScopeAidTM is shown in Table 22 and Figure 28. 
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Table 22. Sensitivity, specificity and accuracy of ScopeAidTM (Exera images) 
 Sensitivity, % 
(95% CI) 
Specificity, % 
(95% CI) 
Accuracy, % 
(95% CI) 
Features describing strength of 
vascularity of a polyp 
45/59 
0.76 (0.63-0.86) 
48/59 
0.81 (0.69-0.90) 
93/118 
0.79 (0.70-0.86) 
Features describing difference 
in strength of vascularity 
between a polyp and the 
surrounding normal mucosa 
43/59 
0.73 (0.60-0.84) 
47/59 
0.80 (0.67-0.89) 
90/118 
0.76 (0.68-0.84) 
Features describing difference 
in colour between a polyp and 
the surrounding normal 
mucosa 
38/59 
0.64 (0.51-0.76) 
47/59 
0.80 (0.67-0.89) 
85/118 
0.72 (0.63-0.80) 
All features: 53/59 
0.90 (0.79-0.96) 
42/59 
0.71 (0.58-0.82) 
95/118 
0.81 (0.72-0.87) 
 
 
Figure 28. ROC curve generated by using features separately and combined for Exera images 
7.4 Discussion	  
We have developed a novel computer algorithm to differentiate between adenomas 
and hyperplastic polyps by using three features extracted from NBI images: A) the 
difference in magnitude orientation dominance between adenomas and hyperplastic 
polyps, B) the difference in magnitude of orientation dominance between the surface 
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of the polyp and the surrounding normal mucosa and C) difference in colour between 
the surface of the polyp and the surrounding background mucosa. We have shown 
that these three features combined deliver the highest classification accuracy. These 
results are compared to the only other study investigating performance of a 
computer aided classification system for colorectal polyps by Tischendorf and 
colleagues which revealed optimised system performance characteristics of 90% 
sensitivity and specificity of 71% (121). This study also used magnified NBI images, 
but their algorithm utilised different classification ‘features’ and they included larger 
polyps (mean size 8 mm, range 2-40 mm) (which are less likely to be left in situ in 
clinical practice due to a higher risk of harbouring malignancy). The study by 
Tischendorf et al (197) compared a consensus between two experienced 
colonoscopists and their ‘standalone’ classification system, with a ‘safe’ paradigm in 
which a decision to remove the polyp would be made if there was disagreement. 
However, it is not clear at this stage how such systems will interact with human 
operators in routine practice. Experience of computer aided diagnosis (CAD) 
systems developed for CT colonography suggests a ‘second reader’ paradigm may 
be the safest approach, whereby the colonoscopist would make an independent 
classification decision prior to computer analysis (214). How a consensus is reached 
on whether to undertake polypectomy where discrepancy occurs will need to be 
addressed. The classification system performed less well on previously unseen 
Exera images. This may may be due to, in part, different technology behind the two 
processors (Exera used a coloured CCD chips whereas Lucera relies on RGB 
technology). Therefore the colours and textures generated are subtly different. 
The limitations of this pilot study include the small number of polyps used and the 
use of magnified NBI images as colonoscopes with magnification are not routinely 
used in clinical practice. Currently, each polyp has to be delineated through manual 
segmentation, which is time consuming and limits the ability of algorithm to be tested 
in real-life practice. 
Future research will involve further development and external validation of the 
algorithm using previously unseen and non-magnified NBI polyp images. Automatic 
boundary detection (polyp segmentation) and additional classification features will 
enable development of a more robust, user friendly classification device which will 
permit investigation of its impact in routine colonoscopy practice. 
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In conclusion, this pilot study has demonstrated an accurate computer based colonic 
polyp classification system using NBI images, which we hope will encourage future 
development of an integrated automatic classification system for use in routine 
colonoscopy practice. 
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Chapter	  8 Use	  of	  narrow	  band	  imaging	  in	  
characterization	  of	  dysplasia:	  a	  
training	  module	  
8.1 Background	  and	  Aims	  
An adequate quality assurance would need to be provided before optical diagnosis 
became routine clinical practice. In a recently proposed algorithm of how to improve 
the introduction of new endoscopic technologies into daily practice, Rex et al 
proposed that once the acceptable thresholds of performance of new technology 
have been defined and tested in well-designed clinical trials, teaching tools would 
need to be developed (215). For optical diagnosis of small colonic polyps, these 
would need to demonstrate that non-expert colonoscopists working in district general 
hospitals could be trained to achieve accuracies comparable to expert 
colonoscopists in tertiary centres. 
A number of studies have demonstrated that the learning curve for the use of NBI in 
characterizing small polyps is shorter than that for chromoendoscopy (128, 130). 
However it remains unclear how best to train and assess colonoscopists to achieve 
acceptable accuracy (likely to be >93%) of optical diagnosis. 
The primary aim of this study was to develop and validate a training and assessment 
module for small polyp characterization using NBI. 
8.2 Methods	  
8.2.1 Module	  development	  
An initial training needs analysis was carried out through expert consensus (BPS, 
STG, AH and AI) and literature review. 
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Learning objectives were derived from the needs analysis (STG, AH and AI) and the 
training module was developed in Microsoft PowerPoint: mac2008 to meet those 
objectives and split into five chapters. 
1 Clinical significance of small colorectal polyps 
2 Basic principles of NBI 
3 Visualisation of micro-vessels with NBI 
4 Differentiation between adenomas and hyperplastic polyps 
5 Examples (with integrated feedback mechanism) 
 
Still images of small polyps in JPEG or TIFF were sourced from a library of images 
and the ones of highest quality were selected for inclusion in the training and test 
modules. They were annotated with relevant background information, key references 
and detailed diagnostic features. Both vascular pattern intensity (VPI) and pit pattern 
as seen with NBI were used to characterize polyps. Overall darker brown colour, 
prominent thick blood vessels and tubular and oval pits were predictive of 
adenomas. Lighter or the same overall colour when compared to the background 
mucosa, lack of dark thick vessels and thin vessels not surrounding the pits were 
predictive of hyperplastic polyps (127)[Meghana, #1822]. The module incorporated 
learning objectives, summary of key learning points and feedback mechanism. Two 
representative screenshots are shown Figure 29 and Figure 30. 
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Figure 29.  Screenshot from NBI training module 
 
 
Figure 30. Screenshot from NBI training module 
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The test module consisted of still NBI images of 30 polyps (15 adenomas and 15 
hyperplastic polyps) in TIFF format which were then incorporated into individual 
slides (Microsoft PowerPoint:mac2008). 
8.2.2 Module	  validation	  
To assess the construct validity of the test module, we examined the difference in 
performance between participants with different levels of experience. The content 
validity of the training module was assessed by examining the change in 
performance on the test module following training. 
Five colonoscopists highly experienced in advanced imaging techniques, including 
NBI, completed the test module to benchmark expert performance. 
Colonoscopy novices (medical students, research fellows and nurses), registrars 
(trainees) and highly experienced colonoscopists, but with little or no knowledge of 
advanced imaging were recruited prospectively to test the training and test modules. 
Baseline performance was assessed using the test module, which the candidates 
completed in their own time (approximately 5 minutes). Correct answers and 
feedback were not given following the test module. The subjects then completed the 
training module in their own time (approximately 15 minutes) before being 
reassessed on the test module. The post training test module had the same images 
as the pre-training test module but randomized to a different order. Following the 
post-training test module, candidates completed feedback forms about the content 
and format of the teaching package. 
8.2.3 Statistical	  analysis	  
To investigate the initial construct validity, we assumed that the baseline difference 
in accuracy between each of the three groups (novice and expert, novice and 
trainee, trainee and expert) would be 20% (assuming 30% discordant responses). 
Using 1.7% significance level (Bonferroni correction for multiple analysis, 5%/3), 
80% power, 73 independent observations would need to be recorded. However as 
the data are not truly independent (same polyps shown to different observers), we 
assumed that the double the number of observations would satisfy the power 
calculation, requiring a minimum of 5 subjects per group. To examine the content 
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validity, a difference of 10% between pre and post-training test accuracy within 
novice, trainee and experienced groups was assumed to be of clinical importance. 
With 5% significance level and 80% power, and again assuming that data are not 
truly independent, at least 200 observations would need to be recorded, requiring a 
minimum of 7 subjects per group for paired analysis. 
To account for the data not being ‘independent’ of each other, multi level logistic 
regression analysis with cross-classified structure was used to compare the baseline 
performance between groups as well as differences between pre and post-training 
performance of the different groups. 
Inter-observer agreement for polyp diagnosis assessed using a kappa (κ) statistic. A κ 
value <0.20 was regarded as poor agreement, 0.21-0.40 fair agreement, 0.41-0.60 
moderate agreement, 0.61-0.80 good agreement and 0.81-1.00 very good agreement. 
Analysis were done using Stata statistical package, version 9.2. 
8.3 Results	  
8.3.1 Participants	  
Five colonoscopists, all consultant gastroenterologists, very experienced in 
advanced endoscopic imaging completed the test module to benchmark expert 
performance. Seven novices (medical students, clinical research fellows and nurses 
with no prior colonoscopy experience) and seven trainees (gastroenterology and 
colorectal surgeons) and seven experienced colonoscopists (no knowledge on the 
use of NBI in polyp characterisation) were prospectively recruited to test the 
construct validity of the test module and content validity of the training module. Prior 
colonoscopic experience of the participants is shown in Table 23. 
Table 23. Previous colonoscopic experience of participants 
Group Colonoscopy, 
Median (IQR) 
Experienced colonoscopists 1000 (1000-4500) 
Trainees 380 (150-450) 
Novices 0 
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8.3.2 Construct	  validity	  
Expert colonoscopists had accuracy of 95% (95% CI 0.92-0.97) in differentiating 
adenomas from hyperplastic polyps Table 24. Logistic regression analysis 
demonstrated there was significant overall difference in accuracy on the pre-training 
test between different groups of participants (p<0.001). Further Bonferroni adjusted 
comparisons between pairs of groups demonstrated that the accuracy of each group 
of participants is significantly different from the other study groups confirming that the 
construct validity of the test module as it is able to differentiate between participants 
with different levels of experience. 
Table 24. Comparison of baseline accuracy between the groups 
Group Baseline test accuracy 
(95% CI) 
P value 
Experts (n=5) 143/150; 0.95 (0.92-0.97) <0.001 
Trainees (n=7) 158/210; 0.75 (0.67-0.82)  
Novices (n=7) 131/210; 0.62 (0.46-0.77)  
 
8.3.3 Content	  validity	  
There was a significant improvement in accuracy of polyp differentiation post-training 
for all three groups (novices, trainees and experienced colonoscopists), both when 
considered separately and when considered together (Table 25). 
Table 25. Comparison of pre and post-training test accuracy 
Group Pre-training test 
accuracy 
(95% CI) 
Post-training test 
accuracy 
(95% CI) 
P value 
Novices 131/210; 0.62 (0.46-0.77) 176/210; 0.84 (0.78-0.88) <0.001 
Trainees 158/210; 0.75 (0.67-0.82) 188/210; 0.90 (0.84-0.93) <0.001 
Experienced 142/210; 0.68 (0.68-0.74) 176/210; 0.84 (0.76-0.89) <0.001 
All groups 431/630; 0.68 (0.61-0.75) 540/630; 0.86 (0.82-0.89) <0.001 
 
 
Although there was a significant improvement in sensitivity between pre- and post-
training test for novices only specificity improved for all groups (Table 26 and Table 
27). 
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Table 26. Comparison of pre and post-training test sensitivity 
Group Pre-training test sensitivity 
(95% CI) 
Post-training test 
sensitivity 
(95% CI) 
P value 
Novices 70/105; 0.67 (0.48-0.81) 93/105; 0.89 (0.86-0.91) <0.001 
Trainees 89/105; 0.85 (0.77-0.90) 94/105; 0.90 (0.82-0.99) 0.23 
Experienced 83/105; 0.79 (0.70-0.86) 87/105; 0.83 (0.75-0.88) 0.40 
All groups 242/315; 0.77 (0.68-0.83) 274/315; 0.87 (0.83-0.90) <0.001 
 
Table 27. Comparison of pre and post-training test specificity  
Group Pre-training test specificity 
(95% CI) 
Post-training test 
specificity 
(95% CI) 
P value 
Novices 61/105; 0.58 (0.40-0.74) 83/105; 0.79 (0.67-0.88) <0.001 
Trainees 69/105; 0.66 (0.52-0.77) 94/105; 0.90 (0.83-0.94) <0.001 
Experienced 59/105; 0.56 (0.46-0.66) 89/105; 0.85 (0.76-0.91) <0.001 
All groups 189/315; 0.60 (0.52-0.83) 266/315; 0.84 (0.79-0.89) <0.001 
 
8.3.4 Inter-­‐observer	  agreement	  
Expert colonoscopists had very good inter-observer agreement, κ=0.85 (0.73-0.97). 
All groups had at least moderate agreement on post-training test, which represented 
a significant improvement in inter-observer agreement after training (Table 28). 
Table 28. Kappa coefficients for inter-observer agreement for pre and post-training 
Group Pre-training test Post-test test p-value 
Novices 0.05 (-0.03-0.13) 0.56 (0.49-0.64) <0.001 
Trainees 0.39 (0.31-0.46) 0.70 (0.63-0.79) <0.001 
Experienced 0.38 (0.31-0.46) 0.54 (0.46-0.62) 0.005 
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8.4 Discussion	  
This study describes the development of a simple training module that can be 
completed by colonoscopists in their own time and validation of its effectiveness in 
improving accuracy of small polyp characterization by using a test module. Participants 
with different levels of colonoscopic experience were included in the study. All groups 
(novices, trainees and experienced colonoscopists) demonstrated a significant 
improvement in accuracy for differentiation of adenomas and hyperplastic polyps on the 
test module, after completing the training module. The accuracy of trainee 
colonoscopists after the training session was 90%, a performance close to expert and 
greater than that for experienced colonoscopists. This may be because, unlike 
established senior colonoscopists (experienced group), trainees may have been 
exposed to NBI at some point during their training and were more diligent in the training 
phase of the study. An alternative explanation is that they have fewer pre-conceived 
ideas about polyp characterisation compared to the more senior colonoscopists. 
Although the training module improved identification of adenomas for novices only, it 
significantly improved accuracy of characterization of hyperplastic polyps (specificity) 
for all groups of participants. This is particularly important as a key area where 
optical diagnosis could be introduced would be in the diagnosis of distal hyperplastic 
polyps, avoiding polypectomy. 
The improvements in inter-observer agreement following training for all participants 
as demonstrated in our study are consistent with the two most recent studies 
examining the same question (136, 216). Raghavendra et al (136) showed that κ 
values improved significantly for faculty, fellow and residents after training using non-
magnified NBI images, with good agreement overall on the post-training test 
(κ=0.62). Higashi et al (216) reported an improvement to ‘fair agreement’ after 
training for less experienced endoscopists for both NBI with and without 
magnification, but no improvement beyond ‘poor agreement’ for participants with no 
prior endoscopic experience. 
Optical diagnosis using NBI without magnification is an attractive concept for 
physicians, patients and healthcare providers as it could potentially reduce the costs 
associated with colonoscopy and polypectomy (117, 207). Recent studies have 
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demonstrated that expert colonoscopists have a high-confidence optical diagnosis 
accuracy that would probably be acceptable for routine clinical practice. However, 
although the NBI learning curve is thought to be relatively short, with an 
improvement in diagnostic accuracy after as few as 44 polyps (127-129, 216) it is not 
clear how ’expertise’ is best transferred to community gastroenterologists and to 
trainees. This is the first study to confirm construct and content validity of an 
educational tool, which is likely to be a first feasible step in the training in the use of 
NBI for characterization of small polyps. The advantages of this training module are 
that it is relatively quick to complete (15 minutes) and can be done in the 
colonoscopist’s own time, without expert supervision. It can be repeated as many 
times as needed as well as used for self-assessment. As it is a computer-based 
module, it can be easily updated with new information and developed into a web-
based version for wider dissemination. However, additional clinical experience with 
histological feedback on accuracy is likely to be necessary to allow exposure to a 
large number of polyps, therefore accelerating the learning curve. 
This study has a number of limitations. Even though there was a range of 
participants, it was conducted in a tertiary academic centre, where all colonoscopists 
are likely to have been exposed to some information on the use of advanced 
endoscopic imaging. To assess the content validity as accurately as possible, the 
same images were used for the pre and post training test, albeit in a different order. 
However the bias resulting from a self-training learning effect within context of 
test/re-test situation is likely to have been minimal as there is evidence from other 
computer-based training studies that there is little or no learning effect without 
feedback (217). In addition, we used still photos instead of video sequences, which 
are less representative of real clinical practice and it is unclear how the results would 
relate to real-time optical diagnosis. To assess this, prospective multi-centre 
observational studies of diagnostic accuracy of optical diagnosis at colonoscopy will 
need to be performed in community hospitals. 
In summary, we have developed and evaluated a training module on the use of NBI 
in differentiating adenomas from hyperplastic polyps and have shown it to have good 
construct and content validity. This study represents a first step in structured training 
to achieve expertise in optical diagnosis using NBI for colonoscopists based outside 
academic centres. 
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Chapter	  9 Use	  of	  still	  photographs	  as	  photo-­‐
documentation	  in	  endoscopy:	  a	  
quality	  assurance	  study	  
9.1 Background	  and	  Aims	  
For the ‘resect and discard’ policy based on optical diagnosis using NBI to be 
accepted in routine clinical practice, adequate measures need to be in place to 
reassure patients and healthcare providers of the accuracy of diagnosis made. 
These quality assurance measures are vital for accreditation and revalidation of 
colonoscopists trained in optical diagnosis as well as for medico-legal purposes. For 
verification of caecal intubation rate as one of the colonoscopy quality indicators, 
American Society for Gastrointestinal Endoscopy (ASGE) suggest that caecal 
landmarks (appendiceal orifice and caecum with ileo-caecal valve) should be 
photodocumented for every procedure (25). Although still photographs of the 
caecum represent the simplest and easiest verification of caecal intubation, they are 
not completely reliable and it may be a challenge to convince expert reviewers that 
the caecum had been intubated. In one retrospective study, 12 expert colonoscopists 
had widely different opinions on whether still photographs of the caecum were 
indeed representative of the caecum (218). These findings were confirmed in a 
prospective study (137) which demonstrated that although capturing certain 
endoscopic features and using a combination of photographs of caecal landmarks 
could improve confidence that the caecum was intubated, still photography was 
nevertheless suboptimal for documentation of complete colonoscopy. On the other 
hand, videotaping insertion to the caecum is a highly convincing method of 
documentation of caecal intubation, but is not widely available and is probably 
impractical for routine clinical practice. 
If optical diagnosis were to become accepted in routine clinical practice, it is likely 
that, in the first instance, still photographs will be used as a ‘photo-record’. In order 
for these to represent adequate quality assurance, good intra-observer agreement 
between the diagnosis the colonoscopist makes in vivo and using a still photograph 
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of the same polyp at a later date should be demonstrated. In addition, in medico-
legal cases it would be important to demonstrate an agreement between the optical 
diagnosis made by the colonoscopist and post-hoc diagnosis made by an expert 
witness based on the photo-record. 
Studies that have assessed non-magnified NBI for small polyp characterization using 
still images (124, 131) have frequently reported lower diagnostic accuracies compared 
to when diagnosis was made in vivo during colonoscopy (135, 198, 207). This may 
have implications on the use of still photographs to document optical diagnosis. 
The aims of this study were to assess: 
1 Inter-observer agreement for expert reviewers 
2 Intra-observer agreement between optical diagnosis and post-hoc diagnosis 
using still photographs 
9.2 Methods	  
9.2.1 Polyps	  images	  
Polyp images were collected prospectively at St Mark’s Hospital between June 2008 
and June 2009, as part of a ‘Optical diagnosis of small colorectal polyps at routine 
colonoscopy (Detect InSpect ChAracterise Resect and Discard; DISCARD trial) 
(ClinicalTrials.gov identifier: NCT00888771). All polyps had optical and 
histopathological diagnosis, which was the reference standard, documented. Ethical 
approval was obtained from the local review board (Harrow REC 05/Q0405/121) and 
all patients gave written informed consent. 
Each polyp detected was washed to remove mucus and stool, examined and 
recorded using NBI without magnification. High-definition monitors (1080 horizontal 
lines of resolution) and non-magnifying Olympus CF-H260DL colonoscopes with 
Lucera video processors (Olympus, Japan) were used for all procedures. Polyp size 
was estimated using biopsy forceps (2.2mm closed, Radial Jaw3, Boston Scientific, 
Natick, Massachusetts). Polyp morphology was described according to the Paris 
classification [, 2003 #491]. All polyps were biopsied or resected and sent for 
histopathological assessment. The reference standard was histopathology using 
standard haematoxylin and eosin staining of at least six cut levels. An experienced 
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gastrointestinal histopathologist classified all specimens according to World Health 
Organisation (WHO) guidelines (188). The histopathologist was blinded to the 
endoscopic assessment. Polyps >10 mm in size and sessile serrated lesions were 
not included in the study as at present formal histopathology is likely to be always 
required for these lesions. 
Of available images, a research fellow randomly selected 50 for expert review 
without attention to image quality. Without any form of post processing, these 
images, which were of the same size and resolution were then incorporated into a 
slideshow (one polyp image per slide) (Microsoft PowerPoint 2004 for Mac; 
Microsoft, Redmond, WA). 
9.2.2 Expert	  reviewers	  
Four experts in the use of NBI in polyp characterization (AR, ED, JEE, PB) who had 
published widely on the subject were sent a fileshare link for the slideshow and ask 
to evaluate 50 images in their own time. They were asked to comment on the image 
quality (5=the best; 1=the worst) and make a diagnosis (adenoma vs. hyperplastic, 
with high or low confidence). The reviewers were blinded to the lesion location and 
histopathological diagnosis. 
9.2.3 Intra-­‐observer	  agreement	  
Optical diagnosis was made in vivo on 37 out of 50 polyps by a single colonoscopist 
(BPS). Six months later he was shown the still images of the same 37 polyps in the 
slideshow (as expert reviewers) and asked to comment on image quality and 
diagnosis (post hoc results). 
9.2.4 Primary	  and	  secondary	  outcomes	  
Primary outcomes were inter-observer agreement between the expert reviewers and 
agreement between reviewers and optical diagnosis. Secondary outcomes were 
agreement between reviewers for image quality and relation of image quality and 
inter-observer agreement, intra-observer agreement for a single colonoscopist (BPS) 
between optical and post-hoc diagnosis using still photographs and diagnostic 
accuracy for expert reviewers for high vs. low confidence diagnoses. 
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9.2.5 Statistics	  
As this was a pilot study, no formal statistical power calculation was undertaken. The 
strength of agreement between observers was assessed using the kappa statistic. 
The analysis of sensitivity was restricted to true positive cases (neoplastic = 
adenomas), of specificity to true negative cases (non-neoplastic = hyperplastic 
polyps) and all cases were used for the analysis of accuracy. Multilevel logistic 
regression analysis with robust standard errors was used to take into account the 
non-independence of the data. Fisher’s exact test was used to compare the high 
confidence vs. low confidence estimates for sensitivity, specificity and accuracy 
where there was only one observer. Where there were multiple comparisons, p 
values were adjusted (Bonferroni correction). The chi-square test for trend was used 
to examine the association of image quality with accuracy. Data are reported 
according to STARD and QUADAS guidelines (205, 206). 
9.3 Results	  
9.3.1 Polyps	  
Non-magnified NBI images of 50 polyps (34 adenomas, 16 hyperplasic polyps) were 
assessed. Mean polyp size was 3.4 mm (SD 1.7). There were 45 sessile (0-Is), 4 flat 
elevated (0-IIa) and 1 pedunculated (0-Ip) lesion. All adenomas contained low grade 
dysplasia and there were no sessile serrated lesions. 
9.3.2 Agreement	  between	  expert	  reviewers	  
Expert reviewers had good overall agreement (κ=0.67; 95% CI 0.55-0.78) in terms of 
polyp diagnosis. However, agreement was only fair (κ =0.46; 95% CI 0.39-0.53) 
when degree of confidence was taken into account (adenoma high confidence, 
adenoma low confidence, hyperplastic high confidence, hyperplastic low 
confidence). There was a significantly better agreement for high quality images than 
for low quality images (κ=0.93 vs. κ=0.53, p=0.002) as well as for those assessed 
with high confidence compared to those with low confidence (κ=0.90 vs. κ=0.20, 
p<0.001). 
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9.3.3 Intra-­‐observer	  agreement	  
There was a moderate agreement between in vivo optical diagnosis and post hoc 
results of one observer assessed (BPS) (κ=0.63, 95% CI 0.31-0.95). The agreement 
between expert reviewers and BPS’ in vivo diagnosis is shown in Table 29. 
Table 29. Agreement between expert reviewers and in vivo diagnosis made by BPS 
Expert reviewer Agreement with BPS in vivo diagnosis 
Κappa (95% confidence intervals) 
PB 0.62 (0.36-0.89) 
JEE 0.82 (0.54-1.00) 
ED 0.77 (0.50-1.00) 
AR 0.82 (0.54-1.00) 
9.3.4 Sensitivity,	  specificity	  and	  accuracy	  of	  diagnosis	  
Sensitivity, specificity and accuracy of diagnosis for all expert reviewers are shown in 
Table 30. 
Table 30. Sensitivity, specificity and accuracy of diagnosis for expert reviewers 
Expert observer Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Accuracy 
(95% CI) 
PB 26/34 
0.76 (0.59-0.89) 
15/16 
0.94 (0.70-1.00) 
41/50 
0.82 (0.69-0.91) 
JEE 32/34 
0.94 (0.80-0.99) 
14/16 
0.88 (0.62-0.98) 
46/50 
0.92 (0.81-0.98) 
ED 31/34 
0.91 (0.76-0.98) 
14/16 
0.88 (0.62-0.98) 
45/50 
0.90 (0.78-0.97) 
AR 32/34 
0.94 (0.80-0.99) 
14/16 
0.88 (0.62-0.98) 
46/50 
0.92 (0.81-0.98) 
Combined (*) 121/136 
0.89 (0.80-0.94) 
57/64 
0.89 (0.73-0.96) 
178/200 
0.89 (0.82-0.93) 
 
(*) Confidence intervals calculated using robust standard errors to allow for non-independence of data 
All three measures were higher for diagnoses made with high confidence than with 
low confidence, although the results were only of borderline statistical significance 
for specificity (Table 31). 
125 
Table 31. Sensitivity, specificity and accuracy of diagnoses made with high vs. low confidence 
 High confidence 
estimate (95% CI) 
Low confidence 
estimate (95% CI) 
p-value 
Sensitivity 94/100 
0.94 (0.87-0.97) 
27/36 
0.75 (0.60-0.85) 
0.007 
Specificity 45/47 
0.96 (0.84-0.99) 
12/17 
0.71 (0.35-0.91) 
0.06 
Accuracy 139/147 
0.95 (0.89-0.97) 
39/53 
0.74 (0.59-0.84) 
0.001 
 
There was no relation between perceived quality of the images and sensitivity, 
specificity and accuracy of the diagnoses made by expert reviewers (Table 32). 
 
Table 32. Sensitivity, specificity and accuracy of diagnoses for low vs. high quality images 
 Lower image quality (1-
3) estimate (95% CI) 
Higher image quality (4-
5) estimate (95% CI) 
p-value 
Sensitivity 57/66 
0.86 (0.72-0.94) 
64/70 
0.91 (0.79-0.97) 
0.68 
Specificity 28/34 
0.82 (0.59-0.94) 
29/30 
0.97 (0.77-1.00) 
0.20 
Accuracy 85/100 
0.85 (0.74-0.92) 
93/100 
0.93 (0.84-0.97) 
0.45 
9.4 Discussion	  
The demand for quality control of endoscopic procedures has grown steadily over 
the last few years. Patients and health care providers, whether these are public 
healthcare systems or insurance companies, require at the very least the proof that 
the procedure has been performed but also performed in a satisfactory manner. In 
addition, the rising trend of medical litigation requires endoscopists to provide 
objective evidence of their performance. This has led endoscopic societies to 
propose quality indicators, which include image documentation (25, 219). Studies 
that have assessed caecal photography to document a complete colonoscopy have 
highlighted inconsistent recognition of caecal landmarks with significant inter-
observer disagreement between photograph reviewers (137, 218). Caecal 
videotaping is highly convincing of caecal intubation and is reliable (137) but the 
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logistics involved in storing and accessing information make it impractical at present. 
Previous literature suggests that accuracy of polyp characterisation is lower using 
still photographs than in vivo diagnosis, which could have significant impact on 
quality assurance of optical diagnosis. 
The present study demonstrates good overall agreement between expert reviewers 
in terms of diagnosis made using still photographs. In terms of agreement between 
reviewers’ diagnoses made on the basis of still photographs and a single 
colonoscopists’ in vivo optical diagnosis, it varied, but was typically good, and very 
good for two of the experts. Unsurprisingly, the inter-observer agreement was better 
for images perceived to be of higher quality, highlighting the importance of taking 
clear images, having cleaned the lens of the colonoscope and washed the stool and 
mucus off the polyp surface. Freezing of the image should be repeated as often as 
necessary until a satisfactory image is obtained and then recorded and stored. 
Sensitivity, specificity and accuracy of three of 4 expert reviewers is comparable to 
or even better than that reported in literature. It has been suggested that should 
optical diagnosis become routine clinical practice, colonoscopists will have to 
demonstrate accuracy of polyp characterization of greater than 90% (D. Rex, 
personal communication). However, sensitivity, which is the number of adenomas 
correctly diagnosed is probably more relevant than specificity, as it is likely that the 
harm that results from leaving an adenoma in situ is likely to be greater than 
polypectomy of a hyperplastic polyp. Three of the expert reviewers had an accuracy 
of >90% when diagnosing adenomas, with two of them approaching accuracy of 
95%, comparable to that achieved at optical diagnosis in vivo (Chapter 5: In-vivo 
characterization of dysplasia). 
Those diagnoses that were made with high confidence by expert reviewers were 
more likely to be accurate, in terms of sensitivity, specificity and overall accuracy, 
than those made with low confidence. This again, is consistent with published 
literature, both when making diagnosis using still photographs (128) and in vivo 
during routine colononscopy (135). Although, inter-observer agreement was better 
with high quality images, this did not translate into improved accuracy of the 
diagnosis, where although it led to numerically higher sensitivity, specificity and 
accuracy, it did not reach statistical significance. This of course may be due to the 
fact that images deemed level 1-3 were combined together into ‘low quality’ group 
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and 4-5 in the high quality group – dividing assessment of quality into fewer groups 
may have revealed significant differences between them. 
The main limitation of this study is the relatively small number of images used. In 
addition the study of intra-observer data would ideally need both more images and a 
greater number of observers with enough data available for assessment of intra-
observer variability. 
In summary, we have shown that high quality still photographs of polyps are 
adequate record of optical diagnosis and performance of a colonoscopist, with good 
inter-observer agreement and accuracy of diagnosis when reviewed by independent 
expert colonoscopists. The record would not only serve as a quality indicator, but 
also documentation of performance in medico-legal cases. It may be that video-
recording is even better and more reliable quality assurance tool, but that remains to 
be answered in future studies. As the technology improves, the impracticalities 
associated with video-recording may become obsolete, but in the meantime still 
photographs of polyps appear to suffice. It is unclear how many images of each 
polyp need to be taken, but on the basis of this study we recommend obtaining at 
least one good quality image, both with conventional white light and NBI for the 
purposes of quality assurance. 
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Chapter	  10 Conclusions	  and	  future	  directions	  
This thesis has examined whether new colonoscopic technologies can improve 
detection and in vivo characterisation of dysplasia. Although colonoscopy is a gold 
standard for detection of dysplastic lesons, a miss rate is recognised and 
colonoscopy has been found not to be protective for right- sided CRC. One 
explanation rests with inability to visualise the right colon in patients who have 
technically difficult colonoscopy. The randomised controlled trial of the use of MEI in 
patients with technically difficult colonoscopy did not show statisticaly significant 
improvement in caecal intubation rates, although all participants were very 
experienced colonoscopists with documented high caecal intubation rates. It is likely 
that MEI will be of benefit in less experienced colonoscopists and trainees and this 
will need to be tested in a large randomised multi-centre study. 
Once the caecum has been reached and mucosa cleaned, adequate extubation 
technique is required in order to maximise the ability to detect subtle lesions. NBI 
enhances mucosal contrast and two studies in this thesis considered whether it 
improved detection of dysplasia. The first examined the use of NBI in patients with 
long-standing colitis. This was a first randomised, parallel arm, multi-centre study 
directly comparing NBI with WLE. The results showed that NBI did not lead to higher 
dysplasia detection rates compared to WLE, a finding consistent with two other studies 
published on the use of NBI in dysplasia detection in UC. Although this study was 
stopped early, it is unlikely that inclusion of more patients would have altered the 
findings. The second study was a meta-analysis of six randomised controlled studies 
on the use of NBI for detection of dysplasia. In this study, again, the use of NBI did not 
lead to improved detection of adenomas, although most of the studies included had a 
higher ADR than is reported in routine clinical practice. This is in contrast to 
hyperplastic polyps, where in pooled analysis NBI improved detection by, on average, 
75%, when compared to WLE. There has been considerable recent interest in sub-
type of hyperplastic polyps ‘sessile serrated adenomas’, as precursor lesions to 
microsatelite unstable (MSI-H) sporadic CRC. NBI may therefore have no role in 
detection of adenomas at colonoscopy, but may be useful in detecting sessile serrated 
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adenomas to aid CRC prevention. Therefore, in future studies hyperplastic polyps and 
sessile serrated adenomas need to be included in the outcome measures. 
Increased use of colonoscopy combined with improved polyp detection rates as a 
result of advances in colonoscopic technology, has resulted in spiralling costs 
associated with the procedure as well as resultant histopathology. The NHS Bowel 
Cancer Screening Programme (BCSP) was introduced in 2006 and offers faecal 
occult blood screening every two years for patients aged 60-75, followed by 
colonoscopy for those who test positive. This has resulted in a dramatically 
increased demand; approximately 80,000 colonoscopies were performed within the 
BCSP since 2007 and at least one adenoma was found in just under half of all 
procedures (M. Rutter, personal communication). From 2011, flexible sigmoidoscopy 
will be introduced for screening all adults > 55 years – this extrapolates to an 
estimated 500,000 flexible sigmoidoscopies per year, with 75,000 procedures 
resulting in the identification of least one polyp. Consequently there will be significant 
new demands on current capacity to deliver histology services. An ability to correctly 
diagnose a small polyp (< 10mm) during colonoscopy (optical diagnosis) would allow 
for recto-sigmoid hyperplastic polyps to be left in situ and for small adenomas to be 
resected and discarded without a need to retrieve the polyp for formal 
histopathology. Thus, optical diagnosis would enable surveillance intervals to be 
determined immediately after colonoscopy and as such would potentially lead to 
significant time and cost savings. The risks of polypectomy are relatively uncommon 
but include bleeding and bowel perforation with severe and unwanted effects on 
patients and healthcare costs. Similarly, the costs of unnecessary histology are 
significant; a ‘resect and discard policy’ to reduce the number of unnecessary 
histology was recently estimated to deliver annual savings of $33 million when 
hypothetically applied to colonoscopy screening of the US population (118). 
DISCARD study was a first prospective cohort study that assessed the impact of 
optical diagnosis on colonoscopy surveillance intervals. It demostrated that optical 
diagnosis was feasible and safe in routine clinical practice and would have allowed 
>60% of patients with polyps to be given a follow up colonoscopy date immediately 
after the procedure, representing a significant saving in follow up clinic 
appointments. Future work will address whether a policy of optical diagnosis is 
feasible and safe in clinical practice outside academic centres. DISCARD 2 is a 
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prospective cohort study planned to take place in 5 district general hospitals in the 
North East recruiting over 2000 patients (Appendix 2: Discard 2 – Application for 
RfPB grant). 
A number of studies have shown that is appreciable inter-observer variability when 
characterising small colonic polyps. In the study of inter-observer variation, NBI with 
magnification improved inter-obeserver agreement in expert colonoscopists when 
compared to WLE. The design of this study, using still images was a practical way of 
assessing four-way inteobserver agreement but is likely to have contributed to lower 
diagnostic accuracy than that reported from in vivo characterisation studies. Using 
still images does not allow for assessment of polyps on high-definition monitors from 
different diastances and angles available in clinical practice. As expert 
colonoscopists in general had better inter-observer agreement we assessed how this 
could be improved for less experienced colonoscopists in two studies. The first 
explored the development of a computer-based algorithm for small polyp 
characterisation, by exloiting the features that reflect clinically observed differences 
in the strength of vascularity and colour between these two types of polyps. The pilot 
results demonstrated that the algorithm developed using features extracted from NBI 
images could accurately differentiate adenomas from hyperplastic polyps. Future 
work will involve developing a more robust algorithm expoliting further features and 
different classifiers. Automatic boundary detection (polyp segmentation) will enable 
development of a more robust, user-friendly classification device, which will permit 
investigation of its impact in routine clinical practice. It is not clear at the moment 
how the algorithm will interact with human operators in routine clinical practice – it 
may be that it acts as a ‘second reader’ paradigm, where colonoscopist would make 
an independent classification decision prior to computer analysis. The second study 
assessed the impact of a training module on NBI characterisation and showed that 
accuracy of polyp characterisation and inter-observer agreement improved 
significantly for colonoscopists with all levels of experience after completing the 
module. This is consistent with the two other most recent studies addressing the 
same question (136, 216). 
For the ‘resect and discard’ policy based on optical diagnosis using NBI to be 
accepted in routine clinical practice, adequate measures need to be in place to 
reassure patients and healthcare providers of the accuracy of diagnosis made. It is 
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likely that in the first instance, the still photographs will be stored for purposes of 
quality assurance of optical diagnosis. Using still images recorded as part of 
DISCARD study and showing them to four expert colonoscopists, we have 
demonstrated that high quality still photographs of polyps are adequate record of 
optical diagnosis and performance of a colonoscopist, with good inter-observer 
agreement and accuracy of diagnosis when reviewed by independent expert 
colonoscopists. The record would not only serve as a quality indicator, but also 
documentation of performance in medico-legal cases. 
In conclusion, advanced colonoscopic technologies explored in this thesis did not lead 
to improved detection of dysplasia, but showed a clear benefit with polyp 
characterisation. Optical diagnosis using NBI has a potential to change the current 
practice of management of small colonic polyps, leading to more efficient colonoscopy 
service, which would be to advantage of patients and healthcare providers. 
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